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1.1 Background 
Avian influenza (AI) is an important viral disease caused by type A influenza viruses belonging to the 
taxonomic viral family Orthomyxoviridae. Avian influenza viruses (AIV) cause mild to severe infection 
in a wide range of domestic and wild birds as well as other mammals including humans. AIV are mostly 
detected in waterfowl that inhabit wetland and aquatic environments, for example Anseriformes and 
Charadiiformes. These wild bird species are considered to represent the virus natural reservoirs (OLSEN 
et al. 2006). The 16 hemagglutinine (H1-H16) and 9 neuraminidase (N1-N9) viral subtypes and all HA-
NA subtype combinations have been found in those species (DUGAN et al. 2008; MUNSTER et al. 
2007). AIV especially the subtypes H5N1 and H9N2 can spread rapidly to domestic poultry and cause 
large-scale outbreaks resulting severe damage to the poultry industry. AIV of subtype H5 and H7 are 
divided into 2 groups based on their ability to cause disease and are designated as low pathogenic avian 
influenza (LPAI) and highly pathogenic avian influenza (HPAI) virus (ALEXANDER 2000). Some AIV 
subtypes (e.g. H5, H7 and H9) have also been reported to cross the species barrier and cause disease or 
subclinical infections in humans and other mammals (ALEXANDER 2007a; WHO 2014b).  
The current outbreak of HPAI H5N1 virus began in 2003 and continued to spread in an unpredictable 
manner to almost all Asian countries as well as some countries in Europe and Africa (OIE 2008). HPAIV 
H5N1 is highly contagious among birds, and can be deadly to the domestic poultry. It has become 
entrenched in poultry in some countries, resulting in millions of poultry infections, several human cases, 
and human deaths (WHO 2014b). Thus, outbreaks in poultry have seriously impacted livelihoods, 
economy and international trade in affected countries. The geographically large scale spread of HPAIV 
H5N1 has been discussed to be associated with trade of poultry and poultry products as well as wild bird 
migration (GUAN et al. 2002; CHEN et al. 2005; CHAKRABARTI et al. 2009; TOSH et al. 2011). 
Therefore, the regular surveillance and characterization of the currently circulating H5N1viruses show 
special attention both from domestic poultry and from migratory birds. In Bangladesh, H5N1 viruses of 
clade 2.2 primarily caused disease outbreaks in poultry and become endemic since its first notification in 
2007 (AHMED et al. 2012b). Later in 2011, two new clades (2.3.2 and 2.3.4) were introduced and 
diagnosed from chickens, ducks, quails and feral crows (ISLAM et al. 2012). Several epidemiological 
evidences suggested that the wild migratory birds are the key factor for the new clade introduction in 
Bangladesh although no virus isolation was reported (AHMED et al. 2011; AHMED et al. 2012a). 
AI H9N2 viruses are characterized as low pathogenic viruses. They became panzootic in the mid-1980s 
among multiple avian species in Asia, the Middle East, Africa and Europe. The H9N2 viruses generally 
cause mild respiratory infections, however nowadays these viruses produce significant disease problems 
with high mortality in poultry. The zoonotic transmission to human has also been reported (PEIRIS et al. 
1999). Furthermore, the prevalence of H9N2 in poultry provides ample opportunity for the acquisition of 
mutations and reassortment (CAPUA and ALEXANDER 2008; WEBSTER et al. 2007). The ability of 
the H9N2 viruses to take part in reassortment events by donating the internal genes to the HPAI subtypes  
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(H5, H7) have raised the possibility to generate a new pandemic potential virus strain (GUAN et al. 1999; 
LI et al 2014). Both HPAIV H5N1 and AIV H9N2 are co-circulating among poultry population in many 
Eurasian countries mostly reported from Bangladesh, China, India, Pakistan, Vietnam, Israel, Egypt and 
United Arab Emirates. Such co-circulations might lead to several mutations followed by reassortment 
which accelerate to generate new AIV strains. The AI outbreaks caused by H5N1 and H9N2 viruses are 
still ongoing events in Bangladesh and Egypt, especially in commercial and backyard chickens which 
become geographically widespread across the respective country, causing serious respiratory infections 
with high mortality rates resulting in severe economic losses. 
 
1.2 Study objectives 
The continuous monitoring, surveillance and molecular characterization of the circulating AIV is of major 
concern. Understanding the role of migratory bird in spreading of these circulating viruses is necessary. In 
addition, it is very important to report the newly circulating strains and to understand their pandemic 
potentiality. Prior characterization, efficient isolation and detection of AIVs from surveillance samples 
are major challenges. Thus, the biological characterization of the circulating influenza viruses is 
important to know the host range, pathogenesis, and receptor specificities which might lead to a 
successful vaccine production. 
 
Therefore, the current study was designed for three primary goals with some additional specific aims: 
 
1) Molecular epidemiology of the HPAI H5N1in migratory birds in Bangladesh 
a) Role of the migratory birds with regard to the introduction of new virus clades  
b) Genetic and phylogenetic relationships between the other circulating H5N1 viruses in poultry  
 
2) Molecular characterization of the AIV subtype H9N2 viruses 
a) Genetic and phylogenetic origin of the isolated viruses 
b) Molecular analysis of mutations and reassortments events 
c) Genome alterations that can influence pathogenesis and host range 
 
3) Biological properties of AIV subtype H9N2 viruses 
a) Replication efficiency of the H9N2 viruses of different origin  
b) Viral growth kinetics in two different biological system  
c) Comparison of different viral quantification methods 
d) Amantadine sensitivities 
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2.1 Avian influenza virus overview 
Avian influenza A viruses, a major cause of acute respiratory tract diseases and have caused significant 
disease outbreaks worldwide (WEBSTER et al. 2005). Clinical signs caused by the virus is called avian 
influenza (AI), commonly described as `bird flu` resulted in great economic losses (WHO 2014b). 
Outbreaks of influenza A viruses continue to cause morbidity and mortality worldwide in domestic birds 
and a wide variety of mammals, including humans. In recent years, a number of AI strains have crossed 
the species barrier also to humans causing severe clinical signs and even death (WEBSTER et al. 2005). 
These include highly pathogenic avian influenza virus (HPAIV) H5N1 which is currently endemic in 
Bangladesh, China, Cambodia, Indonesia, Vietnam and Egypt causing significant mortality (CDC 2012). 
More limited human infections have been associated with another HPAIV of subtype H7, which has been 
detected in poultry workers and veterinarians in the Netherlands and Mexico and the recently emerging 
avian H7N9 viruses in China (CDC 2013 and LI et al. 2014). Less recognized are human infections 
associated with the avian influenza virus (AIV) H9N2 which has characteristics of low pathogenic viruses 
(UYEKI et al. 2012 and CHENG et al. 2011). Although much scientific and public health interest has 
focused on the HPAI H5N1 viruses, the H7 and H9 viruses are also considered to be of pandemic threat. 
During the last two decades, AIV subtypes H5, H9, and H7 have played a major role in influenza 
outbreaks in poultry in Europe and Asia (ALEXANDER 2007a; BROWN 2010). Significant bird 
mortality is recorded especially in Bangladesh, Cambodia, China, Egypt, Indonesia and Vietnam (The 
SJCEIRS working group 2013). 
AIV infect a wild variety of bird species in nature. Wild aquatic birds are generally considered as the 
primary natural reservoir for AIV (WEBSTER et al. 1992) as the 16 hemagglutinin (HA; H1-H16) and 9 
neuraminidase (NA; N1-N9) subtypes of influenza A viruses have been found in these birds worldwide 
(WEBSTER et al. 1992; KALETA et al. 2005; FOUCHIER and MUNSTER 2009; OLSEN et al. 2006). 
Recently two other subtypes of Influenza A virus, H17N10 and H18N11, are identified in bats (TONG et 
al. 2012; TONG et al. 2013). The influenza viruses found in other species were originally derived from 
those of aquatic birds (FOUCHIER et al. 2005). The majority of possible influenza virus H- and N-
subtype combinations are also found in birds of the order Anseriformes, most frequently in dabbling 
ducks such as the mallard (FOUCHIER and MUNSTER 2009; OLSEN et al. 2006). AIV in these wild 
water fowl such as ducks and geese is usually not associated with signs of illness. The distribution of the 
first 16 subtypes of influenza A virus is uneven among all these species of aquatic birds (SPACKMAN et 
al. 2005) and different species have shown variable resistance to influenza virus infection (SPACKMAN 
et al. 2005). 
Interspecies transmission of AIV between wild bird populations and domestic poultry species is an 
occasional event (SUAREZ 2000). Complex interactions between several viruses and host factors are 
needed for successful AIV transmission and adaptation to new hosts (YASSINE et al. 2010). Mutations in 
the virus genome as well as reassortment may allow viruses to cross species barriers, adapt to new hosts,  
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and potentially increase virulence (NEUMANN and KAWAOKA 2006). Generally, it is wild birds that 
introduce AIV to domesticated birds such as chickens, turkeys, quail and other game birds. These 
transmission events occur either through direct contact or contact with contaminated surfaces and water. 
Once the virus has established itself in domesticated birds through adaptation, the potential to spread to 
mammals is increased. 
 
2.2 Virus structure and genome organization 
Influenza A viruses are enveloped, single-stranded negative sense RNA viruses belonging to the 
Orthomyxoviridae family. The virus, with a diameter of ∼100 nm, contains an outer membrane envelope 
and an inner matrix protein layer that enclose a single-stranded, segmented RNA genome (Fig. 1). 
Influenza virus particles are pleomorphic and spherical in appearance (BOURMAKINA and GRACIA-
SASTRE 2003). Each viral RNA segment is folded into a double-helical hairpin structure, as shown by 
the three-dimensional images (TAO and ZHENG 2012). These double-helical hairpin structures, called 
the ribonucleoprotein complexes, play critical roles in virus assembly and infection (YITZHI and 
WENJIE 2012). 
 
 
 
Figure 1: Organization of Influenza A genome. Diagram obtained from DOI: 10.1126/science.1231588 
 
The viral genome consists of eight segments, which encode at least 10 proteins (KNIPE and HOWLEY 
2007). All influenza virus RNA segments contain non-coding sequences at their 5´ and 3´ ends that flank 
the coding region (KNIPE and HOWLEY 2007). The two viral surface glycoproteins HA and NA contain 
the major antigenic determinants (KNIPE and HOWLEY 2007; HORIMOTO and KAWAOKA 2006). 
Influenza A viruses are classified into subtypes based on these two surface proteins (FOUCHIER et al. 
2005). The other six are considered as internal gene segments. The eight segments encoding polypeptide 
and their respective functions are summarized in table 1. 
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Table 1 Avian influenza segments and their encoded polypeptides 
Segm
ent 
Protein name Encoded 
polypeptid
e 
Leng
th (nt) 
Functions 
PB2 Polymerase basic 
2 
PB2 2341 Component of RNA polymerase, cap 
recognition 
PB1 Polymerase basic 
1 
PB1,  
PB1-F2 
2341 Component of RNA polymerase, 
endonuclease activity, elongation 
PA Polymerase acidic PA 2233 Component of RNA polymerase, 
protease 
HA Hemagglutinin HA 1778 Surface glycoprotein, receptor 
binding, fusion activity, major antigen 
NP Nucleoprotein NP 1565 RNA binding, RNA synthesis, RNA 
nuclear import 
NA Neuraminidase NA 1413 Surface glycoprotein, neuraminidase 
activity 
M Matrix M1,  
M2 
1027 M1: interaction with vRNPs and 
surface glycoprotein, nuclear export, 
budding 
M2: ion channel activity, assembly 
NS Nonstructural NS1,  
NS2 (NEP) 
890 NS1: multi-functional, viral IFN 
antagonist 
NS2/NEP: nuclear export of vRNPs 
 
2.2.1 Surface glycoproteins 
The major envelope glycoprotein HA is synthesized in the infected cell as a single polypeptide chain 
(HA0) with a length of approximately 560 amino acid residues, which is subsequently cleaved into two 
subunits, HA1 and HA2 (KNIPE and HOWLEY 2007; STEINHAUER and WHARTON 1998). These 
subunits remain covalently linked to one another through disulphide bonds. Cleavage of HA0 is essential 
for the molecule to be able to mediate membrane fusion between the viral envelope and the host cell 
membrane (KNIPE and HOWLEY 2007; SKEHEL et al. 1982). Cleavage of HA0 to HA1 and HA2 is a 
necessity for virus infectivity and thus determines pathogenicity and spread of infection (KNIPE and 
HOWLEY 2007; STEINHAUER 1999). HA1, the globular domain at the distal end of the spike, is 
responsible for binding of the virus to its cellular sialic acid receptor, the receptor-binding pocket being 
located close to the very tip of the molecule (Fig. 2) (SKEHEL and WILEY 2000). HA1 also contains the 
major antigenic epitopes of the molecule (Fig. 3) (WILEY et al. 1981). HA1 binds to the viral receptor, 
sialic acid residues on host glycoprotein and glycolipids (WILEY and SKEHEL 1987). 
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Figure 2: The three-dimensional structure of the 
influenza HA (H3). The HA monomer (left) and 
trimer (right) are shown 
Source: J Molec Biol 1990; 212: 737–761. 
 
 
 
 
Figure 3: The location of the five major antigenic 
epitopes, A–E, on the HA1 subunit of the influenza 
virus HA (H3) 
Source: J Molec Biol 1990; 212: 737–761. 
 
The virus enters the cytoplasm through fusion of the host and viral membranes via conformational 
changes of the HA2 due to low pH in the endosome (WILEY and SKEHEL 1987; SKEHEL et al. 1982; 
WHARTON 1987). The HA glycoprotein is the viral component that binds to the cell receptor sialic acid 
and a receptor-binding pocket, unreachable to antibodies, is located in the distal head of each monomer 
(KNIPE and HOWLEY 2007) of HA glycoprotein. The amino acid sequences forming this pocket are 
conserved among various subtypes, resulting in different binding specificities to host cells (KNIPE and 
HOWLEY 2007). Most neutralizing antibodies attach to epitopes near the receptor binding sites, which 
for H3 influenza viruses are characterized into five antigenic binding sites located on the globular heads 
(KNIPE and HOWLEY 2007). The hemagglutinin cleavage site is the primary virulence determinant for 
AIV, with the type and the number of basic amino acid at the cleavage sites (CAPUA and ALEXANDER 
2004). HA is the primary viral antigen to which the host's antibody response is directed and the only 
antigen inducing a virus-neutralizing antibody response.  
Besides HA, NA is the other major antigenic molecule located on the surface of the influenza virion. NA 
is a spike–shaped tetramer which inserts within the viral envelope and is the integral membrane protein 
that cleaves sialic acid at its α-ketosidic linkage to adjacent sugar residues (AIR and LAVER 1989). The 
cleavage of sialic acid leads NA to play a role in both viral attachment and viral release from the host cell 
(MATROSOVICH et al. 2004a). The NA inhibitors oseltamivir (Tamiflu®) and Zanamivir (Relenza®) 
bind NA preventing the release of the virus from host cell (MITNAUL et al. 1996). NA also plays a major 
role on antigenic determinant that undergoes antigenic variation. The HA and NA genes are extremely 
variable in sequences and less than 30% amino acids are conserved among all subtype (LEE and SAIF 
2009).  
Chapter2: Review of Literature 
9 
 
 
2.2.2 Internal proteins  
Matrix 
The M1 protein lies beneath the lipid envelope and interacts with the viral ribonucleoproteins (vRNPs). 
M1 is the most abundant protein in the virion and is the primary protein responsible for virus particle 
formation and budding (SKEHEL and SCHILD 1971; GOMEZ-PUERTAS et al. 2000). It also acts as a 
nuclear localization signal (NLS) based on a specific signal sequence (ELSTER et al. 1997) and promotes 
the export of vRNPs from the nucleus to the cytosol as well as the prevention of their re-entry into the 
nucleus (MARTIN and HELENIUS 1991a). 
M2 is another integral membrane protein that extends the entirety of the lipid layer and projects from the 
surface of the virion. M2 forms an ion channel that allows protons (proton acidify the inside of virion 
causing a conformational changes in M1 allowing for the release of vRNPs into cytoplasm) to flow into 
the virion in the endosome during viral entry to the cell (PINTO et al. 1992; SHIMBO et al. 1996). M2 is 
the target for the antiviral drugs amantadine and rimantadine, which blocks the acidification of the virion 
and subsequent releases of vRNPs. 
 
Non-structural proteins 
NS1 and NS2 are the final set of proteins encoded by segment 8 of the genome of influenza A viruses. 
The NS1 is considered multi-functional and important in suppressing the host antiviral response. NS1 has 
been shown to inhibit cytokine response to infection in cell culture (LI et al. 2006; SEO et al. 2002). 
Studies have determined that if NS1 is not present, it can increase the pathogenicity in vivo in mice 
(GRACIA-SASTRE et al. 1998). NS1 bind to the double stranded (ds) RNA preventing activation of the 
dsRNA-dependent protein kinase (PKR), which results in an interferon response (HATADA and 
FUKUDA 1992). In addition to the inhibition the host antiviral response, NS1 modulates host cell 
physiology and viral RNA synthesis (CHEN and KRUG 2000) as well as it has been shown to be 
involved in the induction of apoptosis in infected cells (ZHIRNOV et al. 2002). NS1 can be divided in 
two parts, the RNA-binding domain (CHIEN et al. 2004; HATADA and FUKUDA 1992) and the C-
terminal effector domain, which mediates both the interactions with the host proteins and functionally 
stabilizes the RNA-binding domain (WANG et al. 2002). 
 
NS2 was renamed as nuclear export protein (NEP) when its presence was demonstrated in the virion 
(YASUDA et al. 1993) and involved in nuclear export of vRNPs (O`NEILL et al. 1998). Accumulation of 
NEP triggers the switch from producing mRNA products to transcribing genomic vRNA (ROBB et al. 
2009). NS2 binds to M1 through ionic interactions in the C-terminal domain and is responsible for both 
the nuclear export and for blocking re-entry of vRNPs into nucleus as well as has a nuclear export signal 
that interacts with the protein CRM1 which plays a role in trafficking (SHIMIZU et al. 2011). 
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Nucleoprotein 
The nucleocapsid protein (NP) is the major structural protein that encapsulates vRNA by binding to the 
phosphate sugar backbone of the vRNA (BAUDIN et al. 1994). NP involved in RNA synthesis and 
interaction with the viral RNA polymerase to allow initiation of RNA transcription to form cRNA and 
genomic vRNA (NEWCOMB et al. 2009). Besides binding to PB1 and PB2, NP has been shown to bind 
M1 and several host proteins (PORTELA and DIGARD 2002). 
 
Polymerase Complex 
PB1, PB2 and PA are the three proteins of viral RNA polymerase complex, are encoded on separate 
segments. PB1 and PB2 are the basic proteins whereas PA is the acidic protein and are tightly associated 
to form a compact structure (AREA et al. 2004). The viral RNA polymerase transcribes the viral 
messenger RNA (mRNA), complementary RNA (cRNA) and genomic viral RNA (vRNA). PB1 initiates 
the process of transcription of RNA segments (ULMANEN et al. 1981). PB1 binds both the 5’ and 3’ end 
of the vRNA prior to initiating transcription (ZIEGLER et al. 1999). PB1 is also responsible for 
elongating the growing RNA chain by addition of nucleotides (BRAAM et al. 1983; BISWAS and 
NAYAK 1994).  
The PB2 protein plays a critical role in the initiation of transcription as it responsible for binding the cap 
of host RNA (ULMANEN et al. 1981; BLAAS et al. 1982). In addition to transcription PB2 is also 
involved in replication because some mutations in PB2 have been shown to affect replication but not 
transcription (GASTAMINZA et al. 2003).  
 
Although no specific function has been described for the PA protein, mutations affecting both in 
transcription (FODOR et al. 2002; FODOR et al. 2003) and replication (HUARTE et al. 2003) have been 
described. Moreover, mutations in PA that affect packaging of all genomic vRNA gene segments into the 
virion (LIANG et al. 2012) have been described. The PA subunit has the endonuclease activity 
responsible for cleaving the 5’ cap from cellular mRNA (LI et al. 2001; DIAS et al. 2009; YUAN et al. 
2009). Furthermore, PA plays a role in stabilizing the polymerase complex, cap binding activity as well as 
binding of the polymerase complex to the promoter region of vRNAs (HARA et al. 2006; FODOR et al. 
2002). 
 
2.2.3 PB1-F2, N40 and PA-X 
The PB1 gene also encodes a second protein named PB1-F2 which was first described in 2001 (CHEN et 
al. 2001). PB1 has been found to localize in mitochondria, but is also found in the cytoplasm and nucleus 
of host cells (CHEN et al. 2010) which regulates influenza A virus-mediated apoptosis by targeting the 
mitochondria, contributes to viral RNP activity and aids in viral RNA replication (CHEN et al. 2001; 
GIBBS et al. 2003; YAMADA et al. 2004; ZELL et al. 2007; CHEN et al. 2010). PB1-F2 contributes to 
the pathogenesis of some influenza viruses in the animal model (ZAMARIN et al. 2006; MCAULEY  et 
al. 2007; MCAULEY  et al. 2010a) as well as changes or mutations in the amino acid of HPAI H5N1 can 
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affect pathogenicity (MARJUKI  et al. 2010) and increase virulence (CONENELLO et al. 2007). It has 
also been shown that PB1-F2 can bind PB1 and increase viral RNA-dependent RNA-polymerase activity 
in a tissue and strain dependent manner (CHEN et al. 2010; MARJUKI et al. 2010; MAZUR et al. 2008; 
MCAULEY  et al. 2010b). Intact sequence for PB1-F2 has been found in a high prevalence of AIV, 96% 
of 861 isolates examined (ZELL et al. 2007) has been described.  
 
N40 was first described in 2009 as a protein translated from a separate AUG at PB1 gene segment codon 
40 (WISE et al. 2009). Little is currently known about this protein. It appears to have a role in replication 
in some isolates, but it is neither necessary for viral replication nor expressed by all influenza viruses. PA-
X is the 13th protein hiding in the tiny influenza genome encodes within the PA segment. It was first 
described in 2012 as an overlapping protein-coding region which modulates AIV virulence in a mouse 
infection model, acting to decrease pathogenicity (JAGGER et al. 2012). 
 
2.3 Influenza virus receptors and replication  
Influenza A viruses bind to neuraminic acids (sialic acids, SA) on the surface of host cells to initiate 
infection and replication as illustrated in the overview of the replication cycle (Fig. 4). The viral HA 
protein initiates binding to the host cell via a specific sialic acid (SA) receptor. The SA molecules are 
named α2-3 and α2-6 based on their chemical composition (N-acetylneuraminic acid or N-
glyconeraminic acid) and the galactose sugar linkages to the α2-carbon. Generally, AIV mostly bind to 
the SA with a α2-3 linkage (SA α2-3 Gal), whereas human influenza virus preferentially bind to the SA 
α2-6 Gal (ITO et al. 1997; CONNOR et al. 1994). The fact for such binding preference is that the SA α2-
3 Gal being present in the duck intestinal epithelium (ITO et al. 1997; ITO et al. 2000), while upper 
respiratory tract epithelium of humans contains mostly SA α2-6 Gal (BAUM and PAULSON 1990). 
However, it should be noted that the viral specificity is not absolute as well as avian and human cells can 
contain both SA linkages (KNIPE and HOWLEY 2007). Studies on ciliated cells in the human lower 
respiratory tract have shown that the SA α2-3 linkages are present and these cells can be infected with 
AIV (MATROSOVICH et al. 1999, MATROSOVICH et al. 2004a; MATROSOVICH et al. 2004b; 
SHINYA et al. 2006). The different affinities of HA molecules for different SA receptors is an important 
determinant of host range. On binding at the cell surface, the virus is internalized by receptor-mediated 
endocytosis into the host cell. During the endocytosis the M2 allows influx of protons leading to an acidic 
environment (MATLIN et al. 1981). This low pH in the endosome leads to a conformational changes in 
the HA molecule, which triggers fusion of the viral and endocytic membranes, releasing the vRNPs in to 
the cytoplasm (KNIPE and HOWLEY 2007; MATLIN et al. 1981). Finally, the vRNPs are then actively 
transported into the nucleus through nuclear pores (MARTIN and HELENIUS 1991a), where they serve 
as the template for transcription (KNIPE and HOWLEY 2007). 
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Figure 4: Schematic diagram of influenza virus replication 
 
Inside the nucleus, the polymerase complex initiates primary transcription, beginning with the 
phenomenon of cap snatching (KRUG 1981). Viral RNA-dependent RNA-polymerase initially 
transcribed the vRNA into mRNA. The 5´end of vRNA binds to the PB1 subunit, which allows PB2 to 
recognize and bind to the pre-mRNA (CIANCI et al. 1995; FECHTER and BROWNLEE 2005; LI et al. 
1998). This change in polymerase leads to an increased affinity of PB1 for the 3′ end of the vRNA 
forming a duplex (LEE et al. 2003). The PB1 then exerts its endonuclease activity, cleaving pre-mRNAs 
initiating transcription and chain elongation. The synthesis of viral mRNA is completed with the 
polyadenylation on the 3′ terminus of the newly synthesized RNA. The vRNA segments also serve as 
templates for the production of cRNA but without the need for a capped primer; in this case, an exact 
copy of viral genomic RNA is produced. Once the positive sense cRNA is produced, it serves as the 
template for the production of additional copies of negative sense vRNA. The NP protein is further 
needed to block the viral RNA-polymerase from the creating poly-A-tail and a full transcript (BEATON 
and KRUG 1986). Cellular enzymes are used to splice the mRNA for M1 and M2 as well as NS1 and 
NS2 (CHEN and KRUG 2000). As the M1 protein accumulates in the nucleus it interacts with genomic 
vRNA and inhibits further transcription (WATANABE et al. 1996). Host cellular machinery is used to 
translate viral proteins from mRNA in the cytoplasm (LAMB and CHOPPIN 1976). Once viral 
replication has occurred, the RNP complexes are transported out of the nucleus with the aid of M1, 
NEP/NS2 and an export receptor CRM1 (NEUMANN et al. 2000) for viral assembly (MARTIN and 
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HELENIUS 1991b; O'NEILL et al. 2000). The cytoplasmic tails of HA and NA have a function in 
interacting with M1 in virus assembly and are required for proper virion shape and genomic packaging 
(JIN et al. 1997; ZHANG et al. 2000; BARMAN et al. 2004). It is described that the eight vRNPs are 
incorporated into each virion by a controlled process that requires specific coding signals within each 
segment (FUJII et al. 2003; FUJII et al. 2005; GOG et al. 2007). Influenza viruses assemble at the apical 
plasma membrane, where virus particles bud and are released (KNIPE and HOWLEY 2007).  
 
2.4 Avian influenza pathogenesis and infection 
The ability of influenza A viruses to produce disease varies greatly among host species, virus subtypes as 
well as within viruses belonging to the same subtype. In general influenza A viruses cause mild and 
primary respiratory disease. Clinical signs are generally not associated with severe disease outbreaks in 
poultry, nevertheless, may be exacerbated by other respiratory infections or environmental conditions 
resulting in a much more serious disease. In contrast to these general clinical features, influenza A viruses 
of subtype H5 and H7 can also cause severe disease in chickens. AIV of subtype H5 and H7 are therefore 
classified into low pathogenic (LPAIV) or high pathogenic avian influenza viruses (HPAIV) 
(ALEXANDER 2000; WOOD et al. 1993). Infections with HPAIV cause `fowl plague'. A HPAIV is 
defined as having an intravenous pathogenicity index > 1.2 or causes mortality in at least 6 of 8 
experimentally inoculated chickens (WHO 2002)  whereas, LPAI viruses have pathogenicity index 1 
(OHUCHI et al. 1989; BOSCH et al. 1981; SENNE et al. 1996). LPAI viruses cause localized infections, 
while HPAI is characterized as a systemic disease resulting in high mortality which may reach up to 
100% within 48 h in some poultry species (WHO 2014; SWAYNE and SUAREZ 2000; CAPUA et al. 
2000). 
 
The HA gene and its encoded protein play an important role in influenza pathogenicity. The HA gene 
must be cleaved by a host protease into two separate subunits HA1 and HA2, leaving the fusion peptide 
exposed on the HA2 region which is necessary for the initiation of a productive infection to occur 
(KLENK et al. 1975, LAZAROWITZ and CHOPPIN 1975). The ability of HA to be cleaved is a critical 
component that determines the pathogenicity of AI viruses (BOSCH et al. 1979). Thus, the critical and 
important difference between LPAIV and HPAIV is located at the proteolytic cleavage site of HA 
sequences (GARTEN et al. 1981; KLENK 1980; LAZAROWITZ et al. 1973). HPAIV can be defined as 
having multiple basic amino acids (PEXPKXR/GLFG), whereas LPAI viruses have mono- or di-basic 
amino acids (PQRETR/GLFG) at the HA cleavage site (PERDUE et al. 1997). In HPAI viruses the 
number of basic amino acids (arginine and lysine) can increase through specific mutations or insertions of 
amino acids (HORIMOTO and KAWAOKA 1994; PERDUE et al. 1997; SENNE et al. 1996; WOOD et 
al. 1993) at the cleavage site. The HA of HPAI viruses can be cleaved by ubiquitous furin-like or 
subtilisin-like endoproteases (GARTEN et al. 1981; HORIMOTO and KAWAOKA 1995) which 
increases the ability of the virus to be cleaved in extra-intestinal and extra-respiratory tissues, leading to 
systemic viral replication. In contrast, LPAI viruses have restricted tissue tropism because the cleavage of 
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the HA can only be accomplished by trypsin-like proteases limiting replication to the respiratory and 
intestinal tracts where these enzymes are present (STEINHAUER 1999). The HA of LPAI viruses has 
also been shown to be cleaved by plasmin in cell culture, blood-clotting factor x-like protease in chick 
embryos and tryptase Clara in rat bronchiolar epithelial cells (LAZAROWITZ et al. 1973; GOTOH et al. 
1990; KIDO et al. 1992). 
 
The NA gene has also been suggested to play a role in pathogenesis and host range (GOTO and 
KAWAOKA 1998). Host range restriction of influenza virus is polygenic and efficient replication of 
virus in specific host requires the balanced functions of HA and NA protein and the cooperation of other 
internal proteins (LEE and SAIF 2009). NA is the sialidase which removes the SA to liberate newly 
synthesized viruses from infected cells. A deletion in the stalk region of the NA protein along with 
increased glycosylation in HA was observed (MATROSOVICH et al. 1999) upon experimental waterfowl 
AIV infection of chickens. These nucleotide changes in the NA stalk region have been shown to increase 
pathogenicity in chickens (PERDUE et al. 1995; MUNIER et al. 2010; GIANNECCHINI et al. 2010) and 
to decrease virulence in mice (CASTRUCCI and KAWAOKA 1993) indicating their influence in host 
range alterations. 
 
The NS gene contributed in pathogenesis based on separate amino acid differences located in the NS1 and 
NS2 protein. Amino acid change in the NS1 protein resulted in increased pathogenicity in chickens (LI et 
al. 2006) as well as mutations in NS2 protein showed increase virulence in chicken embryos (PERDUE 
1992). The viral polymerase gene PB2 also plays an integral role in virulence and host range, particularly 
with regard to a specific amino acid found at position 627. At that 627 position, the amino acid lysine has 
been determined in mammalian-origin viruses, whereas in avian-origin viruses the amino acid glutamic 
acid is present (SUBBARAO et al. 1993). HPAI H5N1 and H7N7 viruses isolated from human patients 
have also shown a lysine at position 627, reflecting the adaptation from birds to humans 
(PUTHAVATHANA et al. 2005; FOUCHIER et al. 2004). Thus, changes in the PB2 gene contributes to 
the pathogenesis of avian H5N1 viruses by increasing virulence in mice resulting in systemic spread of 
the virus to non-respiratory organs (HATTA et al. 2001; SHINYA et al. 2004). Overall, there are many 
possibilities that can modulate pathogenesis. Several influenza proteins are described in individual viruses 
as virulence determinants.  
 
2.4.1 Clinical disease in avian species 
In contrast to chicken, ducks infected with HPAIV generally have only subclinical or mild clinical 
symptoms (SHORTRIDGE et al.1998; PERKINS and SWAYNE 2002a; COOLEY et al. 1989; 
ALEXANDER et al. 1986; CAPUA et al. 2001). Occasionally, HPAIV causes severe disease in ducks 
similar to what is seen in poultry. An outbreak of an HPAI H7N1 virus from 1999-2000 in Italy resulted 
in the death of Muscovy ducks and domestic geese (CAPUA et al. 2001). This outbreak caused 
neurologic disease in the Muscovy ducks, which exhibited tremors. Gross pathology included hardening 
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and discoloration of the pancreas and hemorrhagic duodenitis. Histopathologic examination demonstrated 
foci of necrosis of the acinar cells in the pancreas. Additionally, lymphocytic encephalitis and 
perivascular cuffing in the brain was observed (CAPUA et al. 2001). Since 2002, some strains of HPAI 
H5N1 have resulted in high morbidity and mortality of domestic and wild ducks (STURM-RAMIREZ et 
al. 2004; LEE et al. 2005; PANTIN-JACKWOOD et al. 2007; HULSE-POST et al. 2005; BROWN et al. 
2008; LONDT et al. 2008). Clinical signs include cloudy eyes, ruffled feathers, weight loss, respiratory 
signs, diarrhea and weakness (KISHIDA et al. 2005; BROWN et al. 2006b; LONDT et al. 2008). 
Neurologic signs include depression, blindness, loss of balance, ataxia, tremors and paralysis (STURM-
RAMIREZ et al. 2004; KISHIDA et al. 2005; BROWN et al. 2006b; ZHOU et al. 2006). Death most 
frequently occurs between day 3 and 7 post infection (PANTIN-JACKWOOD et al. 2007). Ducks 
infected with HPAI H5N1 viruses shed the virus both orally and cloacally (LONDT et al. 2008). Ducks 
infected with LPAI are asymptomatic and virus replication is primarily restricted to the epithelium of the 
gastro-intestinal tract (ALEXANDER et al. 1978; KISHIDA et al. 2005). Ducks shed virus for 
approximately 3 to 8 days (LATORRE-MARGALEF et al. 2009). The level of LPAI viruses shedding in 
wild mallard populations is inversely correlated with body mass, suggesting natural infections affect the 
health of wild birds (LATORRE-MARGALEF et al. 2009).  
   
Although AIV infection in ducks is mainly an enteric disease, respiratory signs primarily characterize 
LPAIV infection in poultry. Clinical signs of LPAI in chickens include rales, coughing, conjunctivitis and 
airsacculitis (LADMAN et al. 2008) as well as decrease in egg production with the presence of misshapen 
eggs (CAPUA et al. 2000). LPAIV infections in turkeys are similar to chickens (ALEXANDER et al. 
1986). Gross lesions restricted to the respiratory tract, including tracheitis, bronchitis, airsacculitis and 
pneumonia (SHALABY et al. 1994; SWAYNE and SLEMONS 1994). Histologic signs of LPAI in 
chickens and turkeys include loss of cilia, heterophilic infiltrate and luminal exudate in the trachea as well 
as bronchitis and interstitial pneumonia (LADMAN et al. 2008). Some isolates of LPAIV have been 
shown to result in renal tubule necrosis, interstitial nephritis, lymphocyte necrosis and depletion in the 
bursa, spleen and thymus in addition to respiratory pathology (SWAYNE 1997). Virus can usually be 
isolated from lung, trachea and air sac epithelium, but also from the oviduct, ovary and tubular epithelium 
of the kidney with no pathological lesions (SHALABY et al. 1994).  
 
Infection in chickens with HPAIV H5N1 is similar to infection with other HPAI viruses (PERKINS and 
SWAYNE 2001). Mostly described clinical signs were anorexia, cyanosis, ruffled feathers, swollen 
hemorrhagic necrotic wattle and comb, congested legs, dermal hemorrhage and can even include acute 
death without clinical signs (HOOPER et al.1995; KOBAYASHI et al. 1996; PERKINS and SWAYNE 
2001). Gross lesions include subcutaneous edema, mottled pancreas, petechial hemorrhage on the surface 
of serosa, splenomegaly, systemic congestion, pulmonary congestion, pulmonary edema and hemorrhage, 
conjunctival hyperemia and hemorrhage of the enteric tract (KOBAYASHI et al. 1996; PERKINS and 
SWAYNE 2001). The observed histologic lesions include loss of cilia of the respiratory tract, interstitial 
Chapter2: Review of Literature 
16 
 
pneumonia, perivascular cuffing of the brain, gliosis, lymphocytic meningitis, meningoencephalitis, 
nephrosis, nephritis, adrenalitis, myocarditis, myositis, depletion and necrosis of lymphocytes in the 
cloacal bursa, spleen, thymus and cecal tonsils (KOBAYASHI et al. 1996; SWAYNE 1997; PERKINS 
and SWAYNE 2001; TUMPEY et al. 2002; ZHOU et al. 2006). Necrosis is observed in the intestinal 
epithelium, pancreas, spleen, adrenal glands, collecting duct, proximal and distal tubules of the kidney, 
heart, bursa and skeletal muscle (ZHOU et al. 2006; SWAYNE 1997; PERKINS and SWAYNE 2001; 
KOBAYASHI et al. 1996).  
 
HPAIV infections in other waterfowl are usually asymptomatic. Infections in geese include ruffled 
feathers, cloudy eyes, diarrhea, depression, listlessness, seizures, tremors, torticollis, ataxia and in some 
cases death (SHORTRIDGE et al.1998; PERKINS and SWAYNE 2002a; BROWN et al. 2008; ZHOU et 
al 2006). Clinical signs and pathology in swans were described (ELLIS et al. 2004; BROWN et al. 2008) 
with seizures, tremors and ataxia and even acute death without clinical signs. Necrotic foci are seen in the 
liver, spleen, kidney, intestines, proventriculus, cecal tonsils, ovaries and oviduct. Laughing gulls and 
shorebirds are also considered to be a wildlife reservoir for AI, which described asymptomatic for 
infection with a HPAI H5N3 and HPAI H5N1 virus (PERKINS and SWAYNE 2002b; PERKINS and 
SWAYNE 2003). Some more recent HPAI H5N1 isolates cause high morbidity and mortality in laughing 
gulls similar to the affected ducks (BROWN et al. 2006a). In this species, virus were located in air sacs, 
lungs, small intestine, eyes, neurons, glial cells, ependymal cells, pancreatic acinar cells, kidney, heart, 
thymus and endothelial cells (BROWN et al. 2006b). 
 
2.5 Evolution of Influenza A virus 
Influenza A viruses are known for their rapid evolution in aberrant hosts as well as humans although the 
genetic evolution are uncommon in the natural reservoir hosts (WEBSTER and LAVER 1975; OXFORD 
et al. 2003). AIV once introduced into the land based domestic poultry or mammalian species can evolve 
rapidly (LUDWIG et al. 1995). Genomic diversity is acquired through two fundamental mechanisms: an 
intrinsically high rate of mutations and the ability of the virus to reassort their gene segments. Changes in 
viral genomic sequence mainly by mutations or amino acid substitutions over time, is referred to as 
antigenic drift. In contrast, reassortment can yield major genetic changes, referred to as antigenic shift 
(LEWIS 2006). The segmentation of the influenza A genomes facilitates reassortment among strains 
when two or more strains infect the same cell (WEBBY and WEBSTER 2003). The changes in the amino 
acid sequence over time are more likely in the HA and NA genes (NOBUSAWA et al. 1991). Genetic 
drift of the influenza HA protein in poultry occurs at rates similar to those observed in human H3 
influenza viruses that exhibited approximately 7.9 nucleotide and 3.4 amino acid substitutions per year in 
the HA1 gene (BEAN et al. 1992; SUAREZ 2000). The mutation rate of the HA1 of H5 and H7 AI 
viruses from live bird markets in the U.S. showed 7.8 and 4.9 substitutions per 1000 nucleotide sites per 
year, respectively (SUAREZ and SENNE 2000; SPACKMAN et al 2003).  
 
Chapter2: Review of Literature 
17 
 
Antigenic shift could introduce an antigenically distinct virus within a population that is different from 
currently circulating strains, and to which the population has no immunity. This lack of immunity allows 
the virus to spread rapidly within a population, sometimes leading to a pandemic. Important examples of 
known human influenza pandemics due to antigenic shift are the H1N1 subtype in 1918, H2N2 in 1957, 
H3N2 in 1968, H1N1 reappearance in 1977 and most recently, the H1N1-swine origin virus from 2009 
(SALOMON and WEBSTER 2009; VIBOUD et al. 2005; GRENINGER et al. 2010). These pandemic 
events can occur by either the sudden introduction of circulating virus in an animal population to the 
human population or a reassortment event between circulating strains of AI and host-adapted human or 
swine influenza viruses (WRIGHT et al. 2007, DAWOOD et al. 2009). The threat imposed by influenza 
A viruses has been elevated further with the recent introductions of HPAI viruses into the human 
population (SUBBARAO et al. 1998; YAMADA et al. 2006; SHELTON et al. 2011). A very recent 
human infection in China with reassortant influenza A virus subtype H7N9 was recorded. This virus 
contained all 6 internal genes from AIV H9N2 (GAO et al. 2013; KAGEYAMA et al. 2013). 
Additionally, the LPAIV can evolve into HPAIV .The necessary molecular change from LP to HP 
generally occurs when the virus moves from its natural reservoir to poultry species (WEBSTER 1998). 
 
2.6 Epidemiology of avian influenza A virus 
Avian influenza has been known as a disease of birds since the late 1800`s and the virus has continued 
evolving and adapting throughout the world to the present day. AI has not only affected the wild avian 
population and domestic avian species but also has adapted to infect humans, pigs, horses, cats, dogs, sea 
mammals, and other land mammals, with certain strains establishing themselves in these new hosts. AIV 
are responsible for huge economic losses in the poultry industry nowadays especially in Asia. AIV was 
first isolated from a common tern in South Africa in 1961, A/tern/South Africa/61 (H5N3), and was the 
first HPAIV isolate to be recovered from wild birds (BECKER 1966). Viruses were subsequently isolated 
from wedge-tailed shearwaters in Australia (DOWNIE and LAVER 1973) and from wild ducks in 
California (SLEMONS et al. 1974). Since then, it has been determined that all known HA (H1-H16) and 
all known NA (N1-N9) subtypes are found in waterfowl (HINSHAW et al. 1982; OLSEN et al. 2006; 
FOUCHIER et al. 2005). Viruses of the first 16 HA and 9 NA subtypes are maintained in avian species 
leading all mammalian viruses are derived from avian virus pool (WEBSTER et al. 1992). In humans, 
influenza outbreaks apparently occurred in many years ago but in the 20th century, three major pandemic 
have occurred - in 1918 (Spanish influenza, H1N1), 1957 (Asian influenza, H2N2) and 1968 (Hong Kong 
influenza, H3N2). Since then a less severe pandemic occurred at 1977 in Russia (KILBOURNE 2006; 
TAUBENBERGER et al. 2007) followed by the most recent one in 2009 (CDC 2010) that left the world 
with many more questions and answers in how to battle this disease.  
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2.6.1 HPAIV H5N1  
The highly pathogenic H5N1 influenza A virus is of major concern to public health .The devastating virus 
was first observed in China in 1996 (WHO, 2010b) and the first human infection was detected in 1997 in 
Hong Kong (CLAAS et al. 1998; SUBBARAO et al. 1998). After its debut, however, the outbreaks of 
influenza caused by HPAIV H5N1 had not been reported until 2003. The re-emergence of the virus after 
seven years raised major concern in Asia due to its lethal and explosive nature. Within four months after 
its re-occurrence, the virus quickly spread to several Asian countries damaging both domestic production 
and international trade of poultry products resulting in serious economic losses for the domestic industry 
of affected nations (OIE 2011). The virus continued to spread westwards through Asia affecting Russia, 
the Middle East, Europe, and Africa. The HPAI scare peaked in 2006; when not only poultry but also 115 
human cases had been reported - among them 79 patients who did not survive the infection (WHO 
2010a). Human cases are still on-going with significant mortality rates. Out of the 650 documented 
humans HPAIV H5N1 infections worldwide between 2003 and 2014, 386 patients died (WHO 2014a). 
There are a few countries, especially in South and South East Asia, where HPAI H5N1 is no longer 
considered to be an epidemic but an endemic disease. These countries suffer from recurring outbreaks of 
HPAI H5N1 with occasional zoonotic spill-over infections to humans (CHEN et al. 2006a; SMITH et al. 
2006; TRAN et al. 2004). The panzootic spread of HPAIV H5N1 has been attributed to the movement of 
infected poultry and poultry products and in some cases, by wild migratory birds (CHEN et al. 2005; 
GUAN et al. 2002; TUMPY et al. 2002; KWON et al. 2011). Isolation, characterization and genome 
analysis of HPAIV H5N1 from wild migratory birds have been reported from several continents 
(SALZBERG et al. 2007) and in countries like Hong Kong (SMITH et al. 2009), South Korea (KWON et 
al. 2011) and Bangladesh (PARVIN et al. 2014b). Therefore, infection and subsequent spread of HPAI 
H5N1 virus strains in various avian species and mammals as well as humans, posed constant threat to 
human health worldwide (CLASS et al. 1998; PEIRIS et al. 2004). In Asia, HPAI H5N1 outbreaks did 
result in human fatalities in Cambodia, Thailand, Indonesia and Vietnam most often after direct contact 
exposure with infected poultry flocks (KWON et al. 2011). Outbreaks of HPAI in poultry flocks are 
confined only by culling the affected poultry flocks resulting in severe economic damages for the poultry 
industry. 
 
The FAO-OIE-WHO collaboration has been working on measures in order to reduce the risks associated 
with zoonotic infections of influenza viruses. The collaboration collects and updates information on 
HPAIV H5N1. Phytogenic analyses of their HA genes resulted in the distinct classification of twelve 
clades (WHO/OIE/FAO H5N1 Evolution Working Group 2012). These clades are further classified into 
several small sub-clades because HPAIV have evolved through maintenance in the poultry and wild bird 
populations, in part, and possibly due to vaccination of domestic birds in particular regions (CATTOLI et 
al. 2011; LI et al. 2010). Recently, eight new clade designations have been proposed based on division of 
clade 1.1 (Mekong River Delta), 2.1.3.2 (Indonesia), 2.2.2 (India/Bangladesh), 2.2.1.1 (Egypt/Israel), and 
2.3.2.1 (Asia) (WHO/OIE/FAO H5N1 Evolution Working Group 2014). A simplification to the 
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previously defined criteria, which adds a letter rather than number to the right-most digit of fifth-order 
clades, have been proposed by the group to facilitate this and future updates.  
 
A virus of clade 2.2 causes mortalities in wild birds at Qinghai Lake in May 2005 and has spread to 
Europe and Africa (CHEN et al. 2005; LIU et al. 2005). Subsequently, a virus classified as clade 2.3.2 
was isolated from dead birds at the lake between May and June of 2009. The emergence of this virus 
indicate a possible viral adaptation to wild birds and the virus spread further, while the clade 2.2 virus still 
exists (LI et al. 2011). A human case caused by a clade 2.3.2 virus has been reported in 2010 in Hong 
Kong (WHO 2011a). HPAIV of clade 2.3.2 have also been isolated from wild birds in Mongolia in 2008 
and 2009. The HPAI viruses in 2009 could be distinguished from those in 2008 by the origin of the PA 
gene segment (KANG et al. 2011). The rapid evolution of HPAIV H5N1, through both antigenic shift and 
antigenic drift, has generated these distinct clades (WHO, OIE, FAO H, N, and Evolution Working Group 
2008). In this regards the circulation of HPAIV H5N1 raised concerns regarding the potential impact of 
this infection on wild bird, domestic poultry as well as on public health. 
 
2.6.2 AIV H9N2 
AIV H9N2 is wide spread in nature, and is routinely isolated from wild birds and occasionally from pigs 
and other mammalian species (YU et al. 2011). They generally caused mild illness and become panzootic 
in the mid-1980s among chickens, ducks, turkeys, pheasants, quails, ostrich and migratory birds (KNIPE 
and HOWLEY 2007). AIV H9N2 was first detected in the United States in 1966 (HOMME and 
EASTERDAY 1970). In Asia, AIV H9N2 was only detected in domestic ducks in Hong Kong until 
1985(SHORTRIDGE 1992). However, during the 1990s, infections became more prevalent in domestic 
poultry causing disease outbreaks in commercial poultry flocks resulting in severe economic losses in 
many parts of the world especially in some Asian and Middle Eastern countries (SHORTRIDGE 1992; 
WHO 2013). The prevalence of H9N2 viruses in poultry around the world provides ample opportunity for 
the acquisition of mutations and reassortment events (CAPUA and ALEXANDER 2008; WEBSTER et 
al. 2007). By 1997, H9N2 viruses have been isolated in multiple avian species throughout Asia, the 
Middle East, Europe and Africa as well as for the first time from humans in Hong Kong and China, in 
1999 (PEIRIS et al. 1999; PEIRIS et al. 2001). They could emerge as human pathogens through 
reassortment in intermediate hosts, such as e.g. pigs (PEIRIS et al. 2001) and in avian species, or through 
direct adaptation to the human host (GUAN et al. 2000). The AIV H9N2 generally causing mild to 
moderate diseases, however, they have been associated with severe morbidity and mortality in poultry as 
a result of co-infection with other pathogen (BROWN et al. 2006a; NILI and ASASI 2002). Human 
infections associated with mild flu like symptoms (LIN et al. 2000; BUTT et al. 2005) with no evidence 
of human-to-human transmission have been documented. Furthermore, AIV H9N2 isolated from pigs in 
Hong Kong, China and Indonesia has proven the broad host range which might also play a role in the 
generation of new strains (NINOMIYA et al. 2002; YU et al. 2011). Serological studies suggested 
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significant human exposure to these viruses in regions where they became endemic (KHUNTIRAT et al. 
2011; WANG et al. 2009). 
 
Two distinct lineages of H9N2 influenza viruses have been defined, the North American lineage and the 
Eurasian lineages which consists of at least three sub-lineages represented by their prototype strains: 
A/quail/Hong Kong/G1/97 [G1], A/duck/Hong Kong/Y280/9 [Y280], A/Chicken/Beijing/1/94 (BJ94) and 
A/chicken/Korea/38349-P96323/96 [Kr- P96323] (GUAN et al. 1999). The G1-H9N2 is thought to be the 
donor of 6 internal genes to the poultry and the human H5N1 viruses isolated in 1997 (GUAN et al. 
2000). During the last two decades, antigenic and genetic analyses of H9N2 isolates have shown gradual 
and complex diversified evolution (WEBSTER et al. 1992; GUO et al. 2000; DONG et al. 2011). Several 
distinct sub-lineages from the Eurasian lineage have become established in poultry (GUO et al. 2000; 
GUAN et al. 1999). Moreover, H9N2 viruses have undergone reassortment by donating the internal genes 
to currently circulating H5N1, H7N3 and H7N9 viruses (MUNIR et al. 2009; PARVIN et al. 2014a; LI et 
al. 2013; LIU et. al. 2013; GUAN et al. 1999). In addition, some evolved AIV H9N2 acquired human like 
α2,6 SA receptor specificity (MATROSOVICH et al. 2001). Initially affecting poultry, H9N2 viruses 
have been sporadically identified in pigs and humans, which suggested that some of these viruses have 
adapted to bind mammalian host receptor or have acquired mutations that increase mammalian receptor 
specificity (LIN et al. 2000; BUTT et al. 2005; PEIRIS et al. 2001). Therefore the potential risk for these 
viruses to cross the species barriers and affect human health as the consequences of genetic reassortments 
between mammalian and AIV is of major public health concern.  
 
2.6.3 AIV in Bangladesh 
Bangladesh is a country with one of the highest population (1072 people/km2) and poultry densities (1194 
birds/km2) in the world (THE WORLD BANK 2013). The economy of Bangladesh heavily depends on 
its agricultural resources. Livestock especially poultry farming is a promising sector for poverty 
reduction. Approximately 75% of the human population in Bangladesh depends directly on poultry as a 
source of meat and household income (THE WORLD BANK 2013). Unfortunately, outbreaks of diseases 
especially AI are the major constraints in poultry farming in Bangladesh. Moreover, due to the population 
(human and poultry) densities, there is a high risk of rapid disease spread among poultry flocks as well as 
transmission to humans as a potential event of pandemic emerges in Bangladesh.  
 
Both, HPAI H5N1 and AI H9N2 viruses are co-circulating among poultry and village chickens since their 
first reported cases. The HPAIV H5N1 was first detected on February 2007 (OIE 2013) whereas, AIV 
H9N2 was isolated from a sample of a poultry farm collected in September 2006 and characterized later 
(PARVIN et al. 2014a). Thus, AIV H9N2 was circulating in Bangladesh before the first detection of 
HPAIV H5N1. In multiple cases, a closely related progenitor LPAIV has been detected circulating 
immediately prior to an outbreak involving the corresponding HPAIV (KAWAOKA et al. 1984; 
HORIMOTO et al. 1995; SUAREZ et al. 2004) and probably the same has been happened in Bangladesh. 
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HPAI in Bangladesh has since then an apparent seasonal pattern, each wave of outbreaks starting usually 
in the late autumn, reaching the peak in the spring and then declining gradually (AHMED et al. 2011). 
Since the first reported H5N1 outbreak, as many as 779 outbreak units have been reported in 722 
commercial and 57 backyard poultry farms forcing the authority to cull more than 2.5 million chickens 
(WHO/GIP data in HQ 2013). Genetic analyses revealed that, from February 2007 until the end of 2010, 
the circulating HPAI H5N1 viruses in Bangladesh were all from clade 2.2.2; however, at the beginning of 
2011, the introductions of new clades 2.3.2.1 and 2.3.4.2 were detected in chickens, quail, duck, crow and 
migratory birds (FAO 2011; ISLAM et al. 2012; PARVIN et al. 2014b). Migratory birds are considered 
one of the potential causes of these new clade introductions beside other ecological factors (PARVIN et 
al. 2014b). Furthermore, until now seven human cases including one death caused by HPAI H5N1 were 
reported in Bangladesh WHO (WHO 2014a). The first three cases occurred in 2008–2011 in children and 
the isolated viruses belonged to the clades 2.2 and 2.2.2 (WHO 2013; BROOKS et al. 2009). The isolated 
viruses from further reported cases in 2012 and 2013 belonged to clade 2.3.2.1 including the infected 
patient with fatal outcome (ICDDR’B 2013). Nevertheless, the reported H5N1 viruses in humans are the 
reflection of the circulation pattern of H5N1 in poultry throughout the country.   
 
In addition to the sporadic spread of H5N1 viruses, H9N2 influenza viruses have been isolated from live 
bird market as well as from poultry flocks in Bangladesh (NEGOVETICH et al. 2011; 
SHANMUGANATHAM et al. 2013; PARVIN et al. 2014a). Phylogenetically, the Bangladeshi viruses 
belonged to the H9N2 G1 lineage. They also donated internal genes to the contemporary circulating 
HPAIV H5N1 (SHANMUGANATHAM et al. 2013; PARVIN et al. 2014a). Human infection with AIV 
H9N2 was also identified in 2011 (ICDDR’B 2013).  
 
Stamping-out has been the national policy in Bangladesh in combating H5N1 HPAI. However, high 
human and poultry densities, the heterogeneous structure of the poultry industry and inadequate capacity 
of veterinary services hindered the success of stamping out. Recently vaccination against HPAIV H5N1 
has been introduced on a trial basis. AIV H9N2 is still not considered as notifiable in Bangladesh. Active 
avian influenza surveillance in semi-scavenging domestic ducks revealed that these ducks have been 
playing an important role in transmitting AIV especially in winter seasons in Bangladesh. However, the 
current risk of infection for humans from domestic ducks in Bangladesh is negligible (KHATUN et al. 
2013).  
 
2.7 Virus isolation and propagation 
The development of laboratory techniques for efficient isolation and detection of AI virus in surveillance 
samples continue to be a high priority. The embryonated chicken egg (ECE) and cell culture systems are 
generally the basic choice for influenza virus cultivation. Upon receiving a field sample, virus 
propagation and isolation are important for the recovery and production of a viable viral stock for further 
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laboratory use. ECEs are considered the gold standard method of isolation as they are able to support the 
growth of a large spectrum of AIVs and their subtypes. Following an infection in the ECE system, the 
virus initially appears in allantoic membrane epithelium, then in the vascular endothelial cells of 
chorioallantoic membrane and the visceral organs of the embryo. In contrast to the virulent strains, non-
virulent viruses are confined in the allantoic membrane and may not kill the embryo (PARK et al. 2001).  
 
The advantage of the ECE system is the possibility to acquire a large volume of the viral stock (KNIPE 
and HOWLEY 2007) from a single egg, thus, influenza vaccines have traditionally been prepared in 
ECEs (ROBERTSON et al. 1995). The ECE system also allowed high recovery of low-titre field samples, 
depending, however, on host specificity, species and viral subtype. The virulent strains (H5 or H7) of 
AIV rapidly kill the embryos and yield low viral titres. Additionally, microbial contamination, length of 
time necessary for the growth and the unavailability of specific pathogen free (SPF) eggs might be 
considered as limiting factors. Effective AIV isolation can also be performed in the cell culture system. 
The Madin-Darby canine kidney (MDCK) is the cell line of choice for AIV propagation and is also 
recommended by the WHO (WHO 2007). For many years other cell lines have been reported in AIV 
isolation for different purposes. To assess the potential risk of infection with AIVs in mammals, primary 
normal human bronchial epithelial (NHEB) cells (The SJCEIRS working group 2013; ILYUSHINA et al. 
2012), human lung carcinoma cell line (A549) and human muco-epidermoid bronchiolar carcinoma cells 
(NCIH292) (HUSSAIN et al. 2010) have been used. A comparative growth characterization of AIV 
subtypes in different cell lines such as MDCK (HUSSAIN et al. 2010; ILYUSHINA et al. 2012; 
MORESCO et al. 2010; YOUIL et al. 2004; VOETEN et al. 1999), Vero (YOUIL et al. 2004), Tracheal 
Organ Culture (TOC) (PETERSON et al. 2012) and chicken embryo fibroblast cells (LEBAS et al. 2013) 
have also been reported. 
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Introduction 
Influenza A viruses are negative sense, single-stranded, segmented RNA viruses of the family 
Orthomyxoviridae. On basis of the antigenic properties of the glycoproteins haemagglutinin (HA) and 
neuraminidase (NA) influenza A viruses are classified into 18 HA subtypes (H1–H18) and 11 NA 
subtypes (N1–N11) [1]. Based on the molecular analysis and/or in vivo pathogenicity index, avian 
influenza (AI) viruses are classified as either highly pathogenic AI (HPAI) or low pathogenic AI (LPAI).  
The LPAI H9N2 viruses have been recorded in different types of poultry worldwide since their first 
detection from turkeys in Wisconsin in 1966 [2]. These viruses caused disease outbreaks in multiple avian 
species in many parts of the world including Asia, the Middle East, Europe, Africa and USA [3-8]. All 
H9N2 circulating in Asia are belonging to three lineages, G1, Y280 and Kr-p96323 which represented by 
the prototype viruses A/quail/Hong Kong/G1/97, A/duck/Hong Kong/Y280/97, and 
A/Chicken/Korea/38349-p96323/96, respectively, [9,10]. More recently it has been proposed to 
distinguish four clades (H9.1 to H9.4) among the H9 HA genes [11]. Fusaro and others [6] identified four 
distinct and co-circulating groups (designated A, B, C and D) H9N2 viruses in Middle East, each of 
which had undergone widespread inter- and intra-subtype reassorments, leading to the generation of 
viruses with unknown biological properties. 
H9N2 viruses are endemic in poultry populations causing mild to severe respiratory signs, such as 
coughing, sneezing, rales, rattles and excessive lacrimation [5, 12-14]. Other clinical signs are reduction 
in egg production in breeder or layer flocks, as well as a slightly increased mortality [15]. In commercial 
turkeys, LPAI H9N2 viruses are mainly associated with acute respiratory syndromes and drop in egg 
production [16]. Vaccination programs are commonly undertaken in several Asian countries to reduce the 
economic impact of the H9N2 infection in poultry. H9N2 viruses were also recovered from pigs [17], 
demonstrating its broad host range suggesting that it might play a role in the generation of new influenza 
strains of subtype H9. Moreover, the virus have occasionally been transmitted from poultry to humans 
[18-20], raised the pandemic potential of AIV in humans. The virus possesses human virus-like receptor 
specificity and can infect humans producing flu-like illness [21]. Inter-subtype reassortments have been 
detected between the co-circulating H9N2 and the highly pathogenic H5N1 or H7N3 viruses [8, 22, 23]. 
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In Egypt, both HPAI H5N1 and LPAI H9N2 co-circulate among poultry farms causing great economic 
losses. In February 2006, H5N1, clade 2.2.1, was introduced into Egypt presumably by wild birds [24, 
25]. Since then, these viruses have caused devastating losses in the poultry industry and threaten public 
health [7]. In 2010, LPAI H9N2 was also reported from Egyptian broiler and broiler breeder farms for the 
first time [26]. 
The aim of the present study was to investigate H9N2 in commercial broiler and broiler breeder chickens 
suffered from respiratory manifestations. To better understand the genetic background and to elucidate 
potential reassortments, we conducted a phylogenetic analysis of whole genome sequences of the isolated 
H9N2 viruses isolated in 2014. Also the emergence of amino acid mutations and their significance in 
terms of drug resistance, adaptation to different host species, and pandemic potential were examined. 
Materials and methods 
Description of outbreaks and sample collection   
Between January and May 2014, two commercial broilers and one broiler breeder flock showed 
respiratory manifestations in the age of 4-7 weeks. The general clinical signs started with mild respiratory 
manifestations and low mortality rates. Within few days the mortality rates ranged from 8-15%. Trachea 
from 5-10 birds per farm were collected, pooled, labeled and stored at -20 oC until processed for virus 
isolation.  
Virus isolation 
Virus isolation was carried out by inoculation of 10% tracheal homogenate suspension in PBS (PH 7.2) 
containing 1000 IU penicillin and 1 mg streptomycin per ml into 10-day-old embryonated specific-
pathogen-free (SPF, Koam Osheim, El –Fayoum, Egypt) by the allantoic sac route. Daily candling was 
performed and embryonic mortalities were recorded for 7 dpi. The allantoic fluid (AF) was collected from 
eggs irrespective of embryo mortality and subjected to haemagglutination test. 
Virus characterization 
Viral RNA was extracted from the AF using a QIAamp Viral RNA Mini Kit (QIAGEN, Hilden, 
Germany) and reverse transcribed under standard conditions with Re- vertAid Reverse Transcriptase 
(Thermo Scientific, Germany) using the Uni 12 primer [27]. The cDNA was tested for influenza A virus 
by real-time RT-PCR with IAV- M1.2 Mix-FAM targeting the matrix (M) gene as described previously 
[28]. Positive influenza A samples were tested using standard RT-PCR for subtyping H9 using gene-
specific primers [29]. A positive control (A/Chicken/Bangladesh/VP01/2006; accession number 
KC986287) and a negative control (AAFs from uninfected egg) were used to check the specificity of the 
RT-PCR results and to avoid any unexpected amplifications. 
Full-length cloning and sequencing 
RT-PCR was performed for the full-length amplification of all eight genome segments using a slightly 
modified protocol based on that of Hoffmann et al. [27]. Briefly, 3 µl cDNA was added to each 50µl 
reaction mixture containing 10 µl of 5x Phusion buffer (Thermo Scientific, Germany), 1 µl of 10 mM 
dNTPs, 1µl of each primer (10 pmol), 1.5 µl of DMSO, 0.5 µl of Phusion DNA polymerase (2 units/µl) 
and 32 µl of DEPC H2O. The sequence of primers used for amplification of HA, NA, M, PB1, PB2, PA, 
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NP and NS are shown in table (1). The cycler program was as follow: 98 C for 30 seconds (s) followed by 
35 cycles of 98 C for 10 s, 58 C for 30 s and 72 C for 1 min. The final extension was at 72 °C for 10 min. 
PCR products were purified after agarose gel electrophoresis (GeneJET Gel Extraction Kit, Thermo 
Scientific, Germany). The products were cloned (CloneJET PCR Cloning Kit, Thermo Scientific, 
Germany), and plasmid isolation was done from six selected clones for each gene segment. The purified 
plasmids were used for direct nucleotide sequencing using a Rhodamine Dye-Terminator Cycle 
Sequencing Ready Reaction Kit (Big DyeTerminator v1.1; Applied Biosystems), followed by analysis in 
an ABIPRISM TM310 Genetic Analyzer (Applied Biosystems). 
Phylogenetic and molecular genetic analysis 
The sequencing data were initially checked by NCBI BLAST search, assembled, and edited using 
EditSeq (DNASTAR Inc., Madison, Wisconsin). Additional influenza virus sequences data available in 
GenBank were downloaded for comparative phylogenetic analysis of all eight gene segments. The 
selection was based on reference group representatives described in previous studies on H9 lineages and 
nucleotide homology found in the NCBI BLAST search. Selected sequences were subjected to Clustal W 
multiple sequence alignment. Residue analyses were done using the BioEdit 7.1.5 program. A nucleotide 
sequence identity matrix was calculated to determine the homology between the isolates and other 
selected reference isolates. Phylogenetic trees were generated by the distance-based neighbor-joining (NJ) 
method using MEGA version 5.10. Bootstrap values were calculated based on 1,000 NJ replicates of the 
alignment. The nucleotide (nt) sequences obtained from this study were submitted in the GenBank 
database. Individual amino acid (aa) changes in defined conserved regions were analyzed and compared 
with those of LPAI H9 and other subtypes. 
Screening of amantadine sensitivity 
Resistance of the Egyptian viruses to amantadine was assayed in MDBK cell culture according to 
Puthavathana and coworkers [30] after some modifications. Briefly, 104 TCID50 of the tested influenza 
viruses were tested against concentrations of 0, 2.5 and 7.5 µg/ml amantadine (Sigma Aldrich, Steinheim, 
Germany) in microtiter plate by checkboard titration. The MDBK monolayer was washed and pre-
incubated with each drug concentration in Dulbecco’s modified Eagle’s medium (DMEM) containing 
10% fetal calf serum (FCS) and 1% Na-Pyruvate and 1% non-essential amino acid (NEAA) for 30 min. 
In a parallel plate, each titer of virus isolate was incubated with the two different drug concentrations in 
DMEM containing 1% Na-Pyruvate, 1% NEAA and 2µg/ml TPCK-trypsin for 1h at room temperature. 
The drug containing medium in the pre-incubated cell culture plate was replaced by drug –treated virus 
solution from a parallel plate and further incubated for 1 h at 37 °C. Plates were washed and growth 
medium was added containing the desired concentration of drug. Plates were incubated at 37 °C for 24 
hrs. After removal of medium, plates were washed with PBS and fixed with methanol 80% overnight and 
endogenous peroxidase activity was blocked by incubation with 3% (v/v) H2O2 30% for 1 h followed by 
blocking in PBS containing 0.05% Tween and 3% bovine serum albumen. Influenza rabbit anti-
nucleoprotein (Thermo scientific, Rockford, USA) or was added and incubated at RT for 1h. After 
washing with PBS containing 0.05% Tween20, IgG HRP rabbit anti-rabbit antibody (1:1000; Thermo 
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scientific, Rockford, USA) was added and plates were incubated 1 hr at RT. Freshly prepared substrate 
(Dako, Denmark) was added and incubated 20 minutes at RT in the dark. Stop solution (H2SO4, 2.5 M) 
was added and the absorbance OD of the wells was read at 450/650 nm. The mean OD of the infected 
cultures without drug was equal to the total amount of NP protein (100%). Cultures infected with 
amantadine-sensitive virus should produce less than 50% of the total NP protein. 
 
Results 
Virus isolation 
In this study, 3 AI viruses subtype H9N2 were isolated from chickens suffering from respiratory 
manifestations during 2014. Isolation was done in SPF embryonated chicken eggs. All inoculated 
embryos were died after 48 h post inoculation. The infective allantoic fluid was able to agglutinate 
chicken red blood cells. It also reacted positively upon testing with RT-PCR using influenza A primers 
(data not shown). Samples were tested positive for using specific oligonucleotides. However, all samples 
tested negative for H5 with RT-PCR using specific primers (data not shown). The three isolates were 
designated A/chicken/ Egypt/ SCU8/2014, A/chicken/ Egypt/ SCU9/2014 and A/chicken/ Egypt/ 
SCU20/2014.  
Phylogenetic analysis 
RT-PCR for all genome segments; HA, NA, polymerase (PA, PB1 and PB2), nucleoprotein (NP), matrix 
(M) and nonstructural genes (NS) – of the three isolated viruses yielded amplification products of the 
expected size for each segment. After sequence determination, phylogenetic analyses were carried out to 
determine the evolutionary relationships between the isolated AIV H9N2 viruses and the selected isolates 
from the GenBank database. The whole genome sequences of A/chicken/ Egypt/ SCU8/2014, A/chicken/ 
Egypt/SCU9/2014 and A/chicken/ Egypt/SCU20/2014 were deposited in the Genbank database under the 
accession numbers KP027615 to KP027635. Blast analysis of the nucleotide sequences from the eight 
viral genes showed that the isolated Egyptian H9N2 was closely related to the other Middle East H9N2 
strains. The currently isolated viruses shared the common ancestor A/Qa/HK/G1/97 isolate which has 
contributed the internal genes of the H5N1 virus circulating in Asia. The HA, NA, M, PB1, NP alleles of 
the isolated viruses are derived from A/Qa/HK/G1/97 isolate, while the PB2, PA and NS are related to 
A/Chicken/Korea/38349-p96323/96 (Figure 1a-h).  
Surface glycoproteins HA and NA 
The HA of the three isolates showed high homology to the Egyptian chickens and quail H9N2 strains. 
The HA cleavage motif sequence of the A/chicken/ Egypt/SCU8/2014, A/chicken/ Egypt/ SCU9/2014 
and A/chicken/Egypt/SCU20/2014 viruses  were  335RSSR*GLF341 (H9 numbering); thus confirming the 
low pathogenic nature of AI H9N2 in Egypt. The HA of A/chicken/ Egypt/SCU8/2014 and 
A/chicken/Egypt/ SCU20/2014 contained 232NGLIGR237 residue at the left receptor banding site. While 
A/chicken/ Egypt/ SCU9/2014 isolate carries a L234Q substitution (H9 numbering). At the right edge of 
binding pocket motif was 146GTSKS150 (Table 2). The three isolates had five potential glycosylation sites 
at positions 29, 105, 141, 298 and 305 within the HA1 molecule. The A/chicken/Egypt/SCU20/2014 
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isolate carries a S243A substitution in the HA which is not usual in other representative H9N2 isolates. 
Also the A/chicken/ Egypt/SCU20/2014 showed a unique mutation M397I in the HA. The NA gene is 
also closely related to the Egyptian chickens and quail H9N2 strains. The NA of the Egyptian isolates 
contained aa mutations on three loops of hemadsorbing (HB) site compared with HK-G1. The sequences 
of the first, second and third loop were KKDSRA, SDSW and PQE, respectively. The NA stalk deletion 
was absent in all currently isolated viruses. 
Internal proteins 
Genetic analysis of amino acids associated with amantadine resistance in M2 revealed that the currently 
isolated Egyptian isolates had L26, V27, A30, S31 and G34, suggesting that these isolates are amantadine 
sensitive. These viruses had also human specific residues G16, and F55 in M2 gene. A/chicken/ Egypt/ 
SCU9/2014, A/chicken/ Egypt/ SCU20/2014 had K77 in M1 which are not usual in other representative 
H9N2 isolates. The whole length of PB1 (758 aa) was sequenced and analyzed. The 
A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014 Egyptian 
viruses had A14 and Y38. The PB1-F2, 90 aa, of the isolated viruses had S66 which is suggested to 
increase the pathogenicity in mice. Other mutations were found between the three isolates. Also the PB1-
F2 had T68, Q69 and V70 residues in the cytotoxic sequence that contribute to the pathogenesis of the 
disease.  
Amantadine resistance 
Amantadine sensitivity of the A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and 
A/chicken/Egypt/SCU20/2014 viruses was confirmed by drug sensitivity assay in MDBK cells using 
insitu ELISA. All tested viruses were sensitive to amantadine. Amantadine concentrations 2.5 µg/ml or 
7.5µg/ml inhibited the growth of these viruses at titers of 104. The percentages of NP at amantadine 
concentration of 2.5µg/ml were 45, 30 and 34% for A/chicken/Egypt/SCU8/2014, 
A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014, respectively. However at amantadine 
concentration of 7.5µg/ml, there were 28, 31, and 35%, respectively.  
 
Discussion 
Isolation of H9N2 from chickens 
H9N2 influenza virus was identified and described in Egyptian broiler breeder farms for the first time in 
2010 [26]. The present study described H9N2 outbreaks in commercial broiler and broiler breeder 
chickens suffered from respiratory manifestations during the period January to May 2014 and the 
molecular characterization of isolated viruses. The general health signs started with mild respiratory 
manifestation and low mortality rates. Within few days the mortality rates ranged from 8-15%. The high 
mortality could be attributed to opportunistic pathogens or immune-suppression [31, 32].  
In addition to the economic losses, the ability of H9N2 to infect mammals and humans and the potential 
for future reassortment raises their pandemic potential [6, 8]. Three AIV subtype H9N2; 
A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and A/chicken/ Egypt/SCU20/2014 were 
isolated in SPF embryonated chicken eggs. It was very useful to understand the evolutionary status of the 
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recurrent viruses, hence the three recurrent viruses were isolated during short period, the interval between 
the first (A/chicken/Egypt/SCU8/2014) and the last isolate A/chicken/Egypt/SCU20/2014 was less than 5 
months. In addition, due to circulation of H5N1 simultaneously with H9N2 can elucidate potential 
reassortments.  
Whole genome analysis 
The isolated viruses are closely related to the other Middle East H9N2 strains. The virus shared the 
common ancestor A/Qa/HK/G1/97 isolate which has contributed the internal genes of the H5N1 virus 
circulating in Asia. Viruses possessing the gene segment constellation A or B circulated extensively in 
central Asia and the Middle East [6].  
Surface proteins 
The HA glycoprotein is composed of two subunits, the globular surface subunit HA1 and the stalk-like 
transmembrane HA2. The HA protein of influenza viruses is initially synthesized as a single polypeptide 
precursor (HA0)  which is cleaved into HA1 and HA2 subunits by cellular proteases [33]. The HPAI 
viruses contain multiple basic amino acids at HA cleavage sites. The cleavage site motif of 
A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014 viruses 
was PARSSR/GLF indicating that these viruses belong to LPAI. However, the sequence has similar 
genetic constitution to the RX-RYK-R [34] which suggests that these viruses may have the potential to 
acquire basic amino acids needed to become HPAI [5].  
The RBS motif of HA is critical for cellular receptor specificity and determining host range [35, 36]. 
Analyses of the recurrent viruses revealed that A/chicken/Egypt/SCU8/2014 and A/chicken/ 
Egypt/SCU20/2014 contain L234 while A/chicken/Egypt/SCU9/2014 had Q234. The presence Q234 (H3 
numbering: 226) is a typical avian virus signature, and it has been reported that presence of this aa results 
in a preference for binding to α2,3-linked sialic acid (avian receptors) whereas viruses having L234 
showed a preference for α2,6-linked sialic acid (human receptors) and potential cause of reported human 
infections [37]. In addition to RBS, changes in the glycosylation patterns of HA can affect host range and 
virulence of influenza viruses [33]. The three recurrent isolates have five potential glycosylation sites at 
positions 29, 105, 141, 298 and 305 within the HA1 molecule which indicate that these viruses lack one 
site compared with HK-G1. The alteration in the glycosylation pattern influences the adaptation of viruses 
to poultry [38]. Moreover, the loss of an N-linked glycosylation site located near the RBS enhanced virus 
binding to α 2,6- sialic acid [39, 40].  
The NA gene of A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and 
A/chicken/Egypt/SCU20/2014 viruses was also closely related to the recent Egyptian H9N2 strains 
isolated from chickens and quail. The balance between HA and NA is crucial for virus replication and 
transmission. HA binds to sialic acid and NA cleaves it from the host cell surface [41]. The Egyptian 
isolates contained aa mutations on HB sites compared to the recent Egyptian isolates and HK-G1 (Table 
2). This site interacts directly with sialic acid and is associated with NA inhibitor drug resistance. The 
neuraminidase stalk deletion was absent in A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 
and A/chicken/Egypt/SCU20/2014 but it was present in HK-G1. Deletion in the NA stalk region is 
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associated with increased virulence in poultry when AI viruses transmitted from water fowls to domestic 
birds [42]. The shortened NA stalk region of H5N1 viruses was also shown to contribute to virulence in 
mammalian host [43]. 
Internal proteins 
Four critical sites were reported to be associated with amantadine resistance. Single amino acid 
substitutions L26F, V27T, A30T/V and S31N/R in the transmembrane region of the M2 protein may 
confer drug resistance [44]. Amino acid substitutions at 34 or 38 M2 residue could lead to amantadine 
resistance [45]. Analysis of M2 protein aa sequences showed that the A/chicken/Egypt/SCU8/2014, 
A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014 are sensitive to M2-blockers in which 
none of such amino acid substitutions were found. Amantadine sensitivity of these viruses was confirmed 
by a drug-sensitivity assay in MDCK cell cultures.  
The conserved aa residues in M are associated also with host range, increase virulence or replication in 
mammalian host [46]. The A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and 
A/chicken/Egypt/SCU20/2014 had aa substitution I15 V in M1 which is quite common in AI H9N2 
isolates but differ from AIV signatures [8]. The currently isolated Egyptian isolates had three human 
specific residues; E14, G16, and R18 [47, 48]. Also asparagine (N13) to a serine (S) substitution was 
detected in the M2 of both Egyptian strains and the pandemic H1N1 strains [49]. Similar results were 
observed in the A/chicken/Egypt/BSU-CU/11- a recently isolated H9N2 strain [5].  
In recent years, the influenza virus polymerase complex has emerged as a major determinant of 
interspecies transmission and pathogenicity [50]. Molecular analysis of A/chicken/Egypt/SCU8/2014, 
A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014 Egyptian viruses revealed that these 
viruses had E627, N701, and R714 in the PB2. The E627K substitution is the best characterized 
mammalian adaptation and can dramatically increase the pathogenicity [51]. Also the D701N substitution 
caused enhancement of PB2 to importin-alpha1 which is responsible for translocation of the viral 
polymerase to the nucleus in mammalian cells. Interspecies transmission requires adaptation of the viral 
polymerase to importin–α, since avian and human influenza viruses require different importin–α [52, 53]. 
The N701 in the PB2 protein was shown to be a prerequisite for virus transmission in guinea pigs [54]. 
Recently, it has been shown that S714R mutation is also involved in adaptation and that it cooperates with 
D701N in exposing a nuclear localization signal that mediates importin-α binding and entry of PB2 into 
the nucleus, where virus replication and transcription take place [55].  
The mutation S714R and D701N are involved in virus adaptation to mammalian cells by exposing a 
nuclear localization signal that mediates importin-α binding and entry of PB2 into the nucleus, where 
virus replication and transcription take place. 
The A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and A/chicken/Egypt/SCU20/2014 
Egyptian viruses had A14. The V14A substitution in LP PB1 reduced polymerase activity and viral 
shedding and transmissibility but did not affect pathogenicity in chickens [44]. Also the currently isolated 
viruses had Y38. The C38Y substitution into PB1 of LPAI isolated from wild birds demonstrated that this 
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substitution increased both polymerase activity in DF-1 cells in vitro and the pathogenicity of the 
recombinant viruses in chickens [44].  
PB1-F2 is a 90 amino acid protein that is expressed from the +1openreading frame in the PB1 gene of 
some influenza A viruses and has been shown to contribute to viral pathogenicity. A serine at position 66 
(66S) in PB1-F2 is known to increase virulence compared to an isogenic virus with 66N. B1-F2 N66S 
suppresses interferon (IFN)-stimulated genes in mice [56]. The currently isolated Egyptian H9N2 had 
N66S mutation in PB1-F2 protein.  Also the currently isolated Egyptian isolates had T68, Q69 and V70 in 
PB1-F2 protein. Recently, the cytotoxic sequence I68, L69, and V70 of A/Puerto Rico/8/34 PB1-F2 was 
shown to contribute to the pathogenesis of both primary viral and secondary bacterial infections. Viruses 
with the I68, L69, and V70 sequence accelerated development of pneumococcal pneumonia, as reflected 
by increased levels of viral and bacterial lung titers and by greater mortality [57]. The NS1 protein was 
230 aa long and contained the ‘KSEV’ PDZ ligand (PL) motif at the C-terminal end. Most AIVs possess 
ESEV PL motifs at the end of NS1 protein. However for many H9N2 isolates, frequent mutations and 
changes in the PDZ ligand were observed [10]. 
In conclusion, recent LPAIV H9N2 strains were isolated from commercial broiler chickens suffered from 
respiratory manifestations. The viruses were sequenced and compared with selected reference viruses 
from GenBank. The genetic characteristics and mutation trend of the H9N2 virus isolated from chicken in 
Egypt was described.  As influenza outbreaks are still ongoing events in Egypt, it is highly recommended 
to continue monitoring, surveillance and molecular genetic analysis of circulating H9N2 throughout the 
country hence mutations and gene segment reassortments impact the virulence to avian species and could 
lead to emergence of new strains with the capacity to be a pandemic candidate. 
 
Figure legends 
Figure 1(a-h): Phylogenetic analysis of the HA, NA, M, NP, NS, PA, PB1 and PB2 gene of the 
A/chicken/Egypt/SCU8/2014, A/chicken/Egypt/SCU9/2014 and A/chicken/ Egypt/ SCU20/2014 and 
selected H9N2 influenza A viruses from the GenBank and EMBL databases. The strain isolated in the 
current study is indicated in red. The tree was generated by the distanced-based neighbor-joining method 
using MEGA 5.10. The reliability of the tree was assessed by bootstrap analysis with 1,000 replications. 
Bootstrap values ≥ 70% are shown. The scale bar of each tree indicates substitutions per site.  
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1. Introduction 
Avian influenza H9N2 is a low pathogenic avian influenza virus (LPAIV) which in many countries 
continues to cause respiratory diseases, drop in egg production and increase in mortality among 
commercial domestic poultry and wild birds (Brown et al., 2006 ; Nili and Assai, 2002). H9N2 viruses 
become endemic in poultry in many Eurasian countries particularly in some Asian and Middle Eastern 
countries (WHO, 2013). Molecular genetic analyses of H9N2 viruses, isolated during the last two decades 
revealed that these viruses are highly evolving and a genetically diverse population (SJCEIRS working 
group, 2013). Furthermore, H9N2 viruses have reassorted with other avian influenza subtypes to generate 
multiple novel subtype (Li et al., 2005; Garcia-Sastre et al., 2009 and Nagarajan et al., 2009 Xu et al., 
2007A; Xu et al., 2007B). Additionally, its extensive species tropism, distribution and ability to donate 
internal genes to the highly pathogenic H5 and H7 subtypes (Li et al., 2013; Liu et al., 2013; Guan et al., 
1999 and Parvin et al., 2014) evoke particular concerns. The H9 viruses are now also being considered as 
potential pandemic threats, as they have acquired human virus-like receptor specificity (Matrosovich et 
al., 2001) and are able to be directly transmitted from birds to humans (Butt et al., 2005). Two distinct 
lineages of H9N2 influenza viruses, the North American lineage and the Eurasian lineage, have been 
defined. The Eurasian H9N2 viruses further grouped into three sub-lineages: G1, Y280 and Kr-p96323 
based on their antigenic and genetic properties (Guan et al., 2000). The G1-H9N2 viruses are widespread 
and more likely affected in commercial poultry flocks with moderate clinical signs whereas, Y280 and 
Kr-p96323 are apparently circulating in natural reservoir hosts and more prevalent in their respective 
origin areas. Multiple clades of H9N2 viruses such as G1 and Y280 have been circulating together in 
China (Lee et al, 2010). Additionally, H9N2 co circulating with other subtypes especially H5N1 in many 
countries raised the possibility of multiple reassorted viruses. Moreover, human infection with H9N2 
viruses was observed and some of them belonged to the sublineage G1 (Guan et al, 1999; Cheng et al, 
2011; Shaw et al, 2002). Currently the biological properties and risk assessment studies of different clades 
of H9N2 viruses were performed in animal models (SJCEIRS working group, 2013). Assessing the 
fitness of distinct clades of H9N2 showed that the North American H9N2 virus had the lowest risk profile 
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while the Eurasian viruses displayed various levels of fitness across individual assays (SJCEIRS working 
group, 2013). 
Due to the continuous outbreaks of H9N2 in the several mentioned countries, the development of 
laboratory techniques for efficient isolation and detection in surveillance samples continue to be of high 
priority. Upon receiving a field sample, virus propagation and isolation are important for the recovery and 
production of a viable viral stock for further laboratory use. The embryonated chicken egg (ECE) and cell 
culture systems are generally the basic choice for influenza virus cultivation. ECEs are considered the 
gold standard method of isolation as they are able to support the growth of a large spectrum of AIVs and 
their subtypes. The advantage of the ECE system is the possibility to acquire a large volume of the viral 
stock (Knipe and Howley, 2007) from a single egg, thus, influenza vaccines have traditionally been 
prepared in ECEs (Robertson et al., 1995). Effective AIV isolation can also be performed in the cell 
culture system. The Madin-Darby canine kidney (MDCK) is the cell line of choice for AIV propagation 
and is also recommended by the World Health Organization (WHO, 2005). After successful propagation, 
another important observation is the virus quantification. Virus quantification presents a rate-limiting step 
at many stages of vaccine development and production, for both egg and cell culture. Currently, one of 
the most widely used tools for the determination of virus concentration is the viral plaque assay, or 
variations such as tissue/egg culture infectious dose (TCID50/EID50). The viral plaque assay or 
TCID50/EID50 is a subjective and traditional biological technique that was originally applied to the 
quantification of viruses in the early 1950s (Dulbecco, 1952). For influenza viruses, the hemagglutination 
assay (HA) is also widely applied. The HA assay is rapid, requires the use of animal red blood cells, and 
yields an HA titer value that is not readily translated into viruses per ml. Another currently used method 
for virus quantification includes quantitative real time PCR (qRT-PCR). Although the qRT-PCR method 
does not take into account the infectious properties of the virus rather can also detect defective virus 
particles, it is widely used by many researcher.  
 
In this study, four H9N2 isolates from different sources (Three G1-H9N2 and one European wild bird-
H9N2) were propagated separately in two recommended effective biological systems. The virus 
quantification was carried out based on TCID50, HA as well as qRT-PCR simultaneously from all the 
viruses grown on both systems. The morphological changes of the embryos and cells at different time 
points during propagation were observed. Furthermore, the genetic evolution of the viruses in a single 
replication cycle in cell culture was analyzed as well as all four H9N2 viruses were checked for 
amantadine sensitivity. The aim of this study involved the following objectives; i) Replication efficiency 
of the H9N2 viruses of different origin, ii) Growth kinetics of the viruses in two different biological 
system, iii) Correlation between different viral quantification methods iv) Amantadine sensitivity and 
adaptive mutation of the viruses 
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2. Materials and Methods 
2.1 Viruses and cells 
Four Eurasian lineage H9N2 viruses: A/chicken/Bangladesh/ VP01/2006 (BVP01), 
A/turkey/Germany/R869/2012 (GR869), A/chicken/Saudi Arabia/R61/2002 (SAR61) and 
A/chicken/Dubai/ F5/2013 (DF5) were used in this study. Genetically, The BVP01, SAR61 and DF5 
belong to G1 lineage, whereas GR869 is an Eurasian wild bird group (not published).  
Madin-Darby canine kidney cells (both the parental MDCK [ATCC® CCL-34™] and its clone MDCK-II 
[ATCC® CRL-2936™]) were used for efficient viral propagation of the above mentioned viruses.  
 
2.2 Virus propagation in ECE 
Specific pathogen free chicken eggs (VALO BioMedia GmbH, Germany) were used for the ECE 
propagation system. Firstly, the H9N2 viruses were inoculated blindly into the allantoic cavity route of 
10-days-old ECE and incubated at 37°C. Allantoic fluids (AFs) were harvested upon the death of the 
embryo or at 72 hrs post inoculation (hpi). The presence of virus was confirmed by HA and subjected to 
titration. Viral EID50 titers were determined by injecting 100µl of 10-fold dilutions of the virus into the 
allantoic cavities of 10- days-old eggs. For each dilution four eggs were used for accurate calculation of 
the titer. The 50% end points were calculated according to the method of Reed and Muench (1938) for 
50% egg infectious dose (EID50) and are expressed in log10 EID50/ml. The virus stock containing the titer 
of 7.5 log10 EID50/ml was further inoculated into embryonated chicken eggs. Three eggs at each 
incubation period of 2, 8, 16, 24, 32, 40, 48, 56 and 72 hrs were selected and AFs were harvested for the 
assessment of replication kinetics.  
 
2.3 Virus propagation in cell culture  
Confluent monolayers of MDCK and MDCK-II cells were maintained in cell growth medium (CGM) 
consisting of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum 
(FCS), 1% Na-pyruvate and 1% non-essential amino acids (NEAA). Cells were cultured in T-75cm² 
flasks and incubated at 37°C in the presence of 5% CO2. For virus inoculation, confluent monolayer of 
cells was maintained in T-25 cm² flask as well as in 6-well and 96-well microplates for different 
purposes. The inoculum was prepared by diluting the virus in growth medium (GM) [CGM without FCS 
and supplemented with TPCK-trypsin (2µg/ml)] at a moi of 0.2 and inoculated onto the monolayer of 
cells. Infected cells were incubated at 37°C for 1 hr to allow for viral adsorption. Afterwards the 
inoculum was removed and GM was added to the monolayer. The supernatants were harvested at 2, 8, 16, 
24, 32, 40, 48, 56 and 64 hpi and stored at -80°C for virus titration. 
 
2.4 Assessment of viral replication kinetics 
Viral replication kinetics was monitored for infectious particles by tissue culture infectious dose (TCID50) 
assay, hemagglutination (HA) assay as well as for viral particles by qRT-PCR targeting the Matrix (M) 
gene. The influence of H9N2 viruses on cellular morphology was assessed using immunofluorescence. 
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2.4.1 Hemagglutination assay 
The HA assay was performed using 1% washed chicken red blood cells (RBCs) prepared in PBS 
according to the OIE manual (OIE, 2012 ). The harvested AFs and cell culture supernatants (CCSs) at 
selected time points were tested for hemagglutinating activity. The titers were recorded to draw the virus 
replication kinetics and were expressed by hemagglutination titer unit (HAU). Briefly, 25µl of undiluted 
AF/CCS were added to the first wells of 96-well V- bottom shaped plates containing 25 µl/well of PBS. 
Serial two-fold dilutions were performed followed by addition of 25µl PBS to each well. Subsequently, 
25µl of 1% washed chicken RBCs were added to each well and the plates were incubated for 45 min at 
room temperature (RT). The titration was read until the highest dilution giving complete agglutination 
and presented as log2 HAU/25µl. 
 
2.4.2 TCID50 assay 
To determine the infectivity titer, 2×104 cells were seeded in 96-well microplates. The harvested virus 
from each incubation period of both propagation systems was subjected to 10-fold serial dilutions. Six 
replicates of 100µl diluted inoculum were transferred to the monolayers of MDCK-II cells and allowed to 
adsorb at 37°C for 1 hr. The inoculum was discarded and 150µl of GM was added to all wells containing 
monolayers. The cells were incubated at 37°C, 5% CO2 incubator for 32 hrs. The plates were observed for 
cytopathic effect (CPE) and the presence of virus until a certain dilution was confirmed by 
immunofluorescence microscopy. The viral titer was calculated as log10 TCID50/ml as described by 
Karber-Spearman (Spearman, 1908; Kaerber 1931). 
 
2.4.3 Immunofluorescence  
The 96-well microplates containing MDCK-II cells were inoculated with the virus and incubated for 
different time periods. Following incubation cells were washed 3 times with PBS, fixed with 3.7% 
formaldehyde for 10 min at RT and permeabilized with 90% ice cold methanol for 15 min. The plates 
were washed twice with PBS followed by addition of 3% bovine serum albumin (BSA) in PBS as a 
blocking solution and incubated at RT for 30 min. Plates were washed again twice and treated with 
influenza rabbit anti-nucleoprotein (NP) polyclonal primary antibody (PA5-32242, Thermo scientific, 
Germany) at a dilution of 1:5,000. The treated plates were incubated at 37°C for 1 h and washed twice 
with PBS. Secondary antibody (Alexa Fluor® 488 Goat Anti-Rabbit IgG, Life technologies, Germany) at 
1:1,000 dilutions was added and incubated again for 1h at 37°C. Final washing was performed twice and 
the plates were left to dry at RT. To investigate the morphological changes of the cell nucleus, an 
additional stain, 4, 6-diamidino-2-phenylindole (DAPI), was used. The plates were observed under 
fluorescence microscope (Olympus IX70) and images were captured for analysis. 
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2.4.4 Quantitative real time PCR (qRT-PCR) 
RNA was isolated from both AFs and CCSs using QIAmp Viral RNA mini kit (QIAGEN, Hilden, 
Germany) without using carrier RNA provided by the kit and reverse transcribed under the standard 
conditions of RevertAid Reverse Transcriptase (Thermo Scientific, Germany) using the Uni 12 primer 
(Hoffman et al., 2000). Diluted cDNA (1:10) was used for the PCR reaction. A unique primer pair was 
designed to amplify the target sequence of the M gene of AIV type A generating a product of 150 bp 
(primer sequences are available on request). The qRT-PCR reactions were carried out according to the 
manufacturer’s instructions using the Rotor-Gene SYBR Green PCR master mix (QIAGEN, Hilden, 
Germany). A pJET 1.2 BVP/ H9N2-M plasmid was used as a positive control to develop a standard curve. 
The genome copy number was calculated based on the standard curve and expressed as log10 genome 
copies/reaction. 
 
2.5 Adaptive mutations (HA, NA and NS genes) 
To determine the viral adaptive mutations in cell culture, the hemagglutinin (HA), neuraminidase (NA) 
and non-structural (NS) genes were sequenced and analyzed after a single passage. Full length standard 
RT-PCR was performed and the PCR products were purified using GeneJET Gel Extraction Kit (Thermo 
Scientific, City, Germany). The purified products were subjected to direct nucleotide sequencing using 
Rhodamin Dye-Terminator Cycle Sequencing Ready Reaction Kit (Big Dye ® Terminator v1.1; Applied 
Biosystem), followed by analysis in an ABIPRISM™ 310 genetic Analyser (Applied Biosystems). The 
sequence data were edited aligned and analyzed using three software packages (DNASTER, BioEdit and 
MEGA). 
 
2.6 Screening of amantadine sensitivity 
The sensitivity of the studied H9N2 viruses to amantadine was assayed in MDCK-II cells according to 
previously described method with modifications (Puthavathana et al., 2005). Briefly, 104 TCID50 of the 
studied H9N2 influenza viruses were tested against concentrations of 0, 2.5 and 7.5 µg/ml amantadine 
(Sigma Aldrich, Steinheim, Germany) in 96 well microtiter plates by checkerboard titration. The 
MDCK-II monolayer was washed and pre-incubated with each drug concentration in GM for 30 min. In 
a parallel plate, each titer of the virus isolate was incubated with the two different drug concentrations in 
GM for 1 h at RT. The drug-containing medium in the pre-incubated cell culture plate was replaced by 
drug treated virus solution from a parallel plate and further incubated for 1 h at 37°C. Plates were washed 
and GM containing the desired concentration of the drug was added. Plates were incubated at 37°C for 
24 hrs. Following the removal of medium, plates were washed with PBS and fixed with 90% methanol 
overnight at -20°C. Subsequently, endogenous peroxidase activity was blocked by incubation with 3% 
(v/v) H2O2 for 1 hr followed by blocking in PBS containing 0.05% Tween-20 and 3% bovine serum 
albumin. Primary NP antibody was added and incubated at RT for 1hr. After washing with PBS 
containing 0.05% Tween-20, IgG HRP anti-rabbit antibody (Thermo scientific, Germany) at 1:1,000 
dilutions was added and the plates were incubated 1 hr at RT. Freshly prepared substrate (Dako, 
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Denmark) was added and incubated for 20 min at RT in the dark. Stop solution (H2SO4, 2.5 M) was 
added and the absorbance OD of the wells was read at 450/650 nm. The mean OD of the infected 
cultures without drug was equal to the total amount of NP protein (100%). Cultures infected with 
amantadine-sensitive virus should produce less than 50% of the total NP protein. 
 
3. Results 
3.1 Comparison of hemagglutination (HA) titer 
The HA titer was calculated both from the harvested AFs and CCSs of ECE- grown and cell culture-
grown viruses, respectively. All tested H9N2 viruses did not show any differences in titers in MDCK and 
MDCK-II cells, thus only a diagram representative for MDCK-II is shown (Fig. 1B). Most viruses started 
yielding HAU earliest at 16 hpi and reached maximum yield within 32 to 48 hpi which continued until 64 
to 72 hpi (Fig. 1). In the ECE system the currently circulating G1 lineage viruses BVP01, DF5 and 
SAR61 showed higher yields than the European wild type GR869. The highest titers reached by BVP01, 
DF5, SAR61 and GR869 9log2 (512), 9log2 (512), 8 log2 (256) and 5 log2 (32), respectively (Fig. 1A).  
On the other hand, in cell culture propagation system the highest titers recorded by BVP01, DF5, SAR61 
and GR869 were 7log2 (128), 7log2 (128), 5log2 (32) and 3log2 (8), respectively (Fig1B). The ECE-grown 
viruses produced two-fold higher virus yield than the cell culture-grown viruses. 
 
3.2 Replication kinetics based on TCID50  
TCID50 count was performed in MDCK-II cells to quantify the virus infectivity and to compare kinetics 
among the H9N2 viruses grown in the both systems. The ECE- and cell culture-grown H9N2 viruses 
showed detectable titers at 16 hpi and reached maximum titers at 32 hpi (Fig. 2). The infectivity titers of 
all ECE-grown H9N2 viruses varied between 3.5 log10 TCID50/ml to 7.8 log10 TCID50/ml. The ECE-
grown BVP01 and DF5 viruses reached maximum yields (~8 log10 TCID50/ml) followed by SAR61 (~7 
log10 TCID50/ml) and GR869 (~5 log10 TCID50/ml) (Fig. 2A).  
The infectivity titers of cell culture-grown H9N2 strains varied between 2.3 log10 TCID50/ml to 4.9 log10 
TCID50/ml. Furthermore, the cell culture-grown BVP01, SAR61 and DF5 viruses reached maximum 
yields (>4 log10 TCID50/ml) in contrast to GR869 (2.8 log10 TCID50/ml) (Fig. 2B). Thus, the BVP01, 
SAR61 and DF5 viruses grown in both the biological systems achieved maximum titers compared to the 
GR869. Furthermore, all ECE-grown viruses showed higher virus yields than the cell culture-grown 
viruses. 
 
3.3 Comparison of viral genome copy number 
ECE and MDCK-II systems were capable of supporting efficient viral replication and did not measured 
significant differences in genome copy number based on the M gene (Fig. 3). The ECE-grown BVP01 (3 
log10 genome copies/reaction), DF5 (3 log10 genome copies/reaction) and SAR61 (~2 log10 genome 
copies/reaction) viruses showed detectable copy number earliest at 2 hpi. The maximum copy number (~7 
log10 genome copies/ reaction) was obtained earliest at 16 hpi for BVP01 and DF5 H9N2 (Fig 3A) 
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whereas, the maximum copy number (~5.5 log10 genome copies/ reaction) for SAR61 was detected 
earliest at 48 hpi. The European wild type GR869 ECE-grown H9N2 showed detectable copy numbers 
earliest at 8 hpi (1 log10 genome copies/reaction) and reached the maximum (~5 log10 genome 
copies/reaction) earliest at 48 hpi (Fig. 3A).  
On the other hand, cell culture-grown BVP01, DF5, SAR61 and GR869 viruses exhibited detectable copy 
numbers earliest at 8 hpi. The maximum copy number of BVP01 and DF5 was >6 log10 genome 
copies/reaction, detected at 48 hpi. Whereas, the SAR61 showed maximum ~5 log10 genome 
copies/reaction also at 48 hpi and the GR869 showed maximum ~4.3 log10 genome copies/reaction at 56 
hpi (Fig. 3B). 
 
3.4 Morphology and progression of infection 
The general morphology and spread of ECE- and cell culture-grown H9N2 viruses were monitored at the 
specified time points. In ECE propagation, most embryos were alive until the last time point chosen in 
this experiment. However, some embryos showed nonspecific mortality earliest at 32 hpi when infected 
with the same virus and dose, which might be due to the adverse viral influence on the embryos. In the 
cell culture system, both MDCK and MDCK-II cell lines showed similar morphology during infection; 
therefore, only the MDCK-II-derived growth morphology is shown. Firstly, one selected virus (BVP01) 
was confirmed at 32 hpi in MDCK-II cells to check the antibody, selected stains and to adjust the suitable 
control (Fig. 4). On the growth kinetics, the viruses showed CPE in inverted microscope observation 
earliest at 16 hpi, although the viral replication was detected at 8hpi when tested against nucleoprotein 
(NP) of AIV in IF stain (Fig. 5). CPE was more extensive at 48 to 64 hpi and >90% cells have detached 
by 72 hpi. Additionally, on TCID50 count, the presence of virus by producing CPE was confirmed at the 
2nd dilution while the virus was actually present until the 5th dilution as confirmed by IF stain. Thus, the 
TCID50 titers were considered not only based on CPE but also considering the highest dilution where NP 
protein was recognized by IF stain. The progression of viral infection in MDCK-II cells varied in 
morphology at different time points (Fig. 5). Influenza NP protein was detected by IF at the studied time 
points suggestive of a high permissibility and efficient spread of virus infection in the cells. At the early 
time points of infection the viral NP protein was mostly detected in the nucleus and later disseminated to 
the cytoplasm. Significant damage and loss of nuclear structure of the cells at later time points was clearly 
observed by DAPI stain alone. At 64 hpi, very few cells remained attached to the culture plates.  
 
3.5 Sequence analysis and mutation 
The HA, NA and NS genes play important roles in host-virus interactions and virulence. Thus, the 
respective gene sequences of cell culture-grown viruses were compared to the original sequences of the 
stock virus (AF stock passage) used as inoculum. The analysis of the three genes revealed several (2-6) 
nucleotide mutations resulting in 1-2 amino acid substitutions depending on the respective genes (Table 
1). Importantly, none of these nucleotide or amino acid mutations was observed in the conserved region, 
which could have altered pathogenesis or virulence. No amino acid changes were observed at the HA 
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cleavage site, Receptor binding site and within the N-glycosylation sites of the HA protein. All of the 
viruses possessed their respective motif in the PDZ domain at the C terminal end of the NS1 protein as 
inoculum. 
 
3.6 Amantadine sensitivity 
The drug sensitivity of all four studied H9N2 viruses was confirmed using in situ ELISA in MDCK-II 
cells. All tested viruses were shown to be sensitive to amantadine. Amantadine (2.5 µg/ml or 7.5 µg/ml) 
inhibited the growth of all viruses at titers of 4 log10 TCID50/ml. The presence of NP at amantadine 
concentration of 2.5µg/ml was 45%, 34%, 26%, and 55% for BVP01, DF5, GR869 and SAR61, 
respectively. At amantadine concentrations of 7.5µg/ml the presence of NP was accordingly 28%, 34%, 
20% and 45%.  
 
4. Discussion 
Efficient isolation and propagation of influenza viruses is important in epidemiological surveillance, 
study of host-pathogen interactions, diagnosis and vaccine production. Successful and efficient 
propagation of H9N2 virus on ECE and cell culture system depends on viral dose or multiplicity of 
infection (moi), molecular genetic properties of the virus, receptor binding properties of the host cell and 
some other virus- or host-related factors (Lebas et al., 2013; Hussain et al., 2010; Youil et al., 2004). The 
main focus of this study was to evaluate efficient H9N2 virus propagation in two different biological 
systems. Thus, four different geographical sources of H9N2 viruses were propagated in ECEs as well as 
MDCK and MDCK-II cell lines. Analyses of the replication kinetics, correlation between the virus 
quantification methods, virus adaptations to cell culture and the sensitivity to amantadine of the H9N2 
viruses were performed.  
 
The replication of influenza virus in a host cell is a polygenic process depending on the host cell 
endocytic pathways for entry and transfer of viral genome as well as activation of host cell signaling 
(Lakadamyali et al., 2004 and Zhang, 2009). Preferentially, avian influenza viruses bind to terminal α-2,3 
SA linkage, whereas human influenza bind to α-2,6 SA. The allantoic cells of ECEs contain α-2,3 SA Gal 
while the amniotic cells of ECEs and MDCK cells contain both linkages (Ito et al.,1997). Therefore, the 
allantoic cavities are considered to be the preferential sites for avian influenza virus. In this study, four 
H9N2 viruses were propagated and replication kinetics were measured based on HA titer, TCID50 titer 
and qRT-PCR for genome (M) copies. The replication ability of the four virus strains were assessed 
separately in both systems. The four H9N2 viruses were found to grow efficiently in ECEs and cell lines. 
In the cell culture system, both parenteral MDCK and cloned MDCK-II cells were used however; both 
cell lines have shown the same morphology and pattern of replication kinetics. Thus, only MDCK-II 
yields were shown in this study. The cell culture-grown viruses exhibited 2-3 fold lower virus titers than 
the ECE grown virus titers however, in genome copy number it was 1-1.5 fold lower than the ECE grown 
viruses. Although the qRT-PCR method does not take into account the infectious properties of the virus 
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rather can also detect defective virus particles. Among the four studied viruses, the G1 H9N2 (BVP01, 
DF5 and SAR61) isolates achieved maximum virus yields in contrast to the European wild bird (GR869) 
isolate based on HA titer, TCID50 titer as well as on genome copy count.  
 
Generally, all the analyzed strains grew well in both propagation systems, however, the maximum virus 
yields and the earliest time points to achieve highest titers varied with the propagation systems as well as 
with individual viruses. The ECE system allowed rapid replication and yielded maximum titers within 16-
32 h, whereas cell culture supported relatively slow replication and yielded maximum titers after 48 h. In 
addition, the choice of different moi on virus replication is an important issue (Youil et al., 2004). The 
moi of 0.2 used in this study for cell culture, was found to be relatively high as inoculum to generate 
maximum yields at longer time points. More than 80% cells were found detached in both the cell lines 
after 64 hpi. Thus, the ECE-propagated viruses reached relatively higher virus titers compared to cell 
culture-propagated viruses at respective time points. Therefore, the ECE may be considered the better 
system for the primary virus isolation from field samples as well as for the virological surveillance study. 
Specific receptor binding properties of embryos also facilitate better replication of avian origin influenza 
virus compared to cell lines (Rogers and Paulson, 1983). The ECE and cell culture are completely 
different biological systems which possess differential host-related factors involved in efficient viral 
propagation as well as in variation of viral replication kinetics.  
 
The G1 lineage H9N2 viruses are adapted to poultry and produced more severe infections than the other 
representative lineage of H9N2. Thus, the genetic background of all studied H9N2 viruses were also 
considered for achievement of different replication kinetics at both propagation systems. Genetically, the 
BVP01, DF5 and SAR61 belonged to the G1 lineage, while GR869 is a Eurasian wild-type reassortant 
virus isolated from turkey which was not adapted to domestic poultry flocks. Moreover, the genetic 
variation at HA cleavage motif, HA receptor binding site (RBS) and C terminal domain of NS1 protein 
(Table 2) of four studied viruses thought to be involve in achievement of different replication pattern or in 
virus particle count from two propagation systems. The binding property of the virus to the host cell is 
determined by two factors, the RBS affinity of the virus and receptor density on the host cell surface 
(Asaoka et al. 2006). The RBS motif of the HA protein of the BVP01 and DF5 revealed an important 
Q234L (Glutamine to Leucine) mutation, like the HK-G1strain. However, the SAR61 and GR869 viruses 
contain Q at 234 positions (H3 numbering: 226) which is a typical avian virus signature, and it has been 
reported that the presence of this aa results in a preference for binding to α 2,3-linked sialic acid (avian 
receptors) whereas viruses having L234 (H9 numbering) showed a preference for 2,6-linked sialic acid 
(human receptors) besides avian receptor and a potential cause of reported human infections (Wan and 
Perez 2007). 
 
Due to be the member of a separate clade with different HA cleavage motif, RBS as well as NS1C-
terminal domain (Table 2) the GR869 virus showed comparatively lower replication pattern than the other 
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three strains of G1 H9N2. Again it was noticed that within the three studied G1 H9N2 viruses, the BVP01 
and the DF5 produced kinetics were somewhat similar with higher replication profile in contrast of 
SAR61 which showed lower kinetics. Epidemiologically, BVP01 and DF5 viruses were known to induce 
clinical signs and caused mortality in commercial poultry flocks which gives the back draw to yield 
highest titers in all the virus quantification methods taken into account in this study from both the 
propagation systems.   
 
Amantadine blocks the ion channel formed by M2 protein and inhibits the early step of replication. 
Substitutions of amino acid residue such as L26F, V27A, A30T, S31N and G34E of the M2 protein are 
already known to confer resistance to the amantadine (Belsche et al., 1988 and Hay et al., 1986). The 
amino acid residue analysis of M2 protein of all studied H9N2 viruses except one position in DF5 H9N2 
(had substitution S31N), did not showed any substitutions on those mentioned residues (Table 2). 
However, at the amantadine screening on MDCK-II cells at two different concentrations confirmed all the 
studied H9N2 were sensitive to the amantadine M2 blocker drug. The nucleotide sequences of HA, NA 
and NS gene from cell culture-grown viruses did exhibit some mutations compared to the sequence of the 
inoculum. However, none of these substitutions were found to alter molecular determinants of 
pathogenesis.   
 
In conclusion, the virus replication kinetics based on HA titer, TCID50 titer and the viral genome copies 
revealed that the three G1-H9N2 viruses (BVP01, DF5 and SAR61) reached highest kinetic level 
compared to the European wild type H9N2 (GR869) virus probably due to the variable genetic 
constitutions at their specific conserved region. The species variation of the GR869 virus may have also 
affected the replication profile. The virus quantification methods used in this study have a correlation 
among themselves as the ECE-grown and cell culture-grown viruses achieved similar pattern of 
replication kinetics from all the quantification methods. However, this study revealed that the ECE 
propagation system allowed better replication as maximum virus yield were more than the cell culture-
grown viruses. Thus, the replication efficiency of the ECE-grown H9N2 viruses was greater probably due 
to the specific binding property between the virus and the host cell. The different virus quantification 
methods varied insignificantly. All the studied viruses were amantadine sensitive and did not exhibit any 
significant mutations that are required for the alteration of pathogenesis after a single replication cycle. 
This study adds more insights in the growth properties of the Eurosian lineage of avian influenza H9N2 in 
two traditional effective propagation systems which further help in figuring out a suitable system for the 
influenza vaccine production. 
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Figure legends 
Figure 1(A & B): Comparison of four studied H9N2 viruses grown in embryonated chicken egg (A) and 
MDCK-II cell culture (B) system based on  hemagglutination (HA) titer at different time points. 
 
Figure 2(A & B): Replication kinetics of four studied H9N2 viruses grown in embryonated chicken egg 
(A) and MDCK-II cell culture (B) system at different time points. 
 
Figure 3(A & B): Comparison of four studied H9N2 virus grown in embryonated chicken egg (A) and 
MDCK-II cell culture (B) system based on the measurement of M genome copies at different time points. 
 
Figure 4: Confirmation of the presence of influenza BVP01/H9N2 virus at 32hpi in MDCK-II cells 
observed by the anti-NP protein immunofluorescence assay (magnification 20x). A: infected cells positive 
for NP protein; B: mock control negative for NP stain; C: merge between NP and DAPI stain on infected 
cultures and D: mock control positive for DAPI stain.  
 
Figure 5: Progression of infection and viral replication produced by BVP01/H9N2 virus in MDCK-II cell 
at different time points observed by the presence of influenza A anti-NP protein in immunofluorescence 
assay (magnification 20x). I: infected cells positive for NP stain and M: mock control negative for NP 
stain. 
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AIV causes frequent epidemics and occasional pandemics in various animals and thus present a 
significant public health problem associated with considerable economic consequences. AIVs of various 
subtypes are circulating in poultry (ABBAS et al. 2010; JEONG et al. 2010; KIM et al. 2010). In 
particular, H5N1 and H9N2 AIVs are predominant among poultry flocks causing severe disease 
outbreaks with high morbidity and mortality (NAGARAJAN et al. 2009; XU et al. 2007; CAMERON et 
al. 2000) in many Eurasian countries. Thus, the present study was designed to characterize the H5N1 and 
H9N2 AIVs from different sources as well as to assess the replication properties of the H9N2 viruses in 
two biological systems based on different virus quantification methods 
 
6.1 Molecular characterization of H5N1 
Based on the globally observed outbreaks of AI H5N1, many prior researches have focused on 
determining the key factors that influence the H5N1 dispersal as a part of disease surveillance. 
Understanding the major contributors to the disease spread is a crucial first step towards the prevention of 
the deadly influenza. Three notable possibilities contributing to the spread of the H5N1 viruses have been 
described (CHEN et al. 2005; GUAN et al. 2002; TUMPY et al. 2002; KWON et al. 2011). They are; 
movements of poultry and related products, migratory birds that are capable of being healthy carriers of 
H5N1, and ecological factors. This study was carried out to understand the role of migratory birds as a 
source of new clade introduction of H5N1 in Bangladesh. 
In Bangladesh, H5N1 viruses of clade 2.2 caused disease outbreaks in poultry and became endemic since 
its first notification in 2007 (AHMED et al. 2012b). In 2011, two new clades (2.3.2 and 2.3.4) were 
introduced and detected from chickens, ducks, quails and feral crows (ISLAM et al. 2012). Several 
epidemiological evidences suggested that the wild migratory birds are the key factor for the new clade 
introduction in Bangladesh although no virus isolation was reported (AHMED et al. 2011; AHMED et al. 
2012a). The present study demonstrated for the first time the presence of HPAIV H5N1 in the wild 
migratory bird population in Bangladesh (Publication 1). 
 
6.1.1 Role of Migratory birds in the introduction of a new HPAIV H5N1 clade to Bangladesh 
HPAI H5N1 viruses of clade 2.3.2 were first identified in China and Vietnam in 2005 from ducks, geese 
and other mammals (CHEN et al. 2006b; ROBERTON et al. 2006). Between 2006 and 2007, H5N1 
viruses of clades 2.3.2 and 2.3.4 were predominantly isolated from wild birds in Hong Kong (ELLIS et al. 
2009; SMITH et al. 2009). The FAO-OIE-WHO suggested a recent increase of HPAI H5N1 outbreaks 
due to clade 2.3.2.1 in south and south-east Asia. So far, viruses of the same clade were reported from 
India, Lao, Vietnam, Nepal, China, Hong Kong, Russia, Japan and Bangladesh (ROBERTON et al. 2006; 
ISLAM et al. 2012; ELLIS et al. 2009; SMITH et al. 2009). The occurrence of three variants of clade 
2.3.2.1, namely A/Hubei/ 1/2010-like (HB), 2.3.2.1 A/barn swallow/ Hong Kong/D10-1161/2010-like 
(BS) and 2.3.2.1 A/Hong Kong/6841/2010-like (HK), during 2010-2012 in Asia provides evidence for the 
continued incursion of new viruses or the evolution of existing viruses in south-east Asia (FAO 2014). 
Additionally, in some countries like Vietnam, clade 2.3.2.1 has been co-circulating with clade 2.2 and 
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clade 2.3.4 (ISLAM et al. 2012). It is therefore possible that in Bangladesh clade 2.3.2.1 also supercedes 
other clades.  
 
The phylogenetic and molecular genetic analysis of the all eight gene segments of the two isolates 
A/migratory bird/Bangladesh/P18/2010 and A/migratory bird/Bangladesh/P29/2010 revealed genetic 
similarities with the clade 2.3.2.1 viruses as they belonged to the variant HB-like. They maintained the 
direct group relationship with the countries other reported isolates from the clade 2.3.2.1 (ISLAM et al. 
2012). Although some unique amino acid substitutions in the HA gene sequence were observed 
(Publication 1), none of those substitutions have direct relations with the conserved regions that are 
involved in molecular pathogenesis or host pathogen interactions. Detailed pathogenesis studies are 
recommended to understand the function of those substitutions. The phylogenetic origin and sequence 
homology analysis of the migratory bird isolates as well as the epidemiological evidences of AIV 
circulation in Bangladesh (AHMED et al. 2011; AHMED et al. 2012a) strongly suggested that bird 
migration contributes to the new introduction of clade 2.3.2.1 in Bangladesh followed by spread within 
many Asian countries. The possible migration of the studied migratory birds would be within those 
countries (China, Laos, Vietnam, Myanmar and Bangladesh) from where the isolates are genetically 
highly similar and incorporated within the same phylogenetic group (Fig. 5). Broadly speaking, bird 
migration normally exhibits a north- pattern and south-pattern, following coasts, mountain ranges and 
principal river valleys (CHEN and HOLMES 2009) which also supported our prediction on bird 
migration. Moreover, the major migratory flyways, overlapping regions of migration pathways such as 
breeding areas, wintering areas, as well as stop-over points, all provide the opportunity for virus 
transmission among a range of bird species (GARAMSZEGI and MOLLER 2007; STALLKNECHT et 
al. 1990). However, the virus spread and exchange by migratory birds are mostly intra-continental and 
evidence of intercontinental virus exchange is very limited (KRAUSS et al. 2007).  
 
The present study provides virological evidence of presence of HPAI H5N1 in migratory birds and 
highlights the role of migratory birds in the expansion of geographical distribution of AIVs not only in 
Bangladesh but also over the South-East-Asia. However, this study independently is unable to verify 
whether wild birds are carriers or victims. Interestingly, the migratory bird samples that were found 
positive for clade 2.3.2.1 HPAI-H5N1 were obtained even earlier than the first detection of similar 
viruses in  chicken, ducks, quails, crows and environment in Bangladesh. Therefore this study suggested 
that migratory birds are an important source of introduction of new HPAI-H5N1 virus strains in to 
Bangladesh. Extensive virological surveillance is required to further explore the role of migratory birds in 
the molecular epidemiology of HPAI in Bangladesh as well as other Asian countries.   
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Figure 5: Possible migration of the studied migratory birds based on phylogenetic relationship (Illustrated 
on Google map). Yellow arrows indicate the proposed bird migration. 
 
6.2 Molecular characterization of AIV H9N2 
AIV H9N2 subtype has become prevalent in domestic poultry in many countries in Asia and the Middle 
East since the late 1990’s (ALEXANDER 2007a; ALEXANDER 2007b; GUAN et al. 2000; NAEEM et 
al. 1999; AAMIR et al. 2007). Despite being LPAI viruses, these viruses have gained the ability to cause 
severe respiratory diseases accompanied by high morbidity and mortality and a marked reduction in egg 
production (BANO et al. 2003; KISHIDA et al. 2004). The frequent heavy losses incurred with H9N2 
infection have raised the serious concerns for the poultry in many countries. As a consequence of regular 
virological sample investigations we received samples from the poultry flocks of Bangladesh and Egypt. 
A Bangladeshi H9N2; A/chicken/Bangladesh/VP01/2006 (BD-VP01), and three Egyptian H9N2; 
A/chicken/Egypt/SCU8/2014 (SCU8), A/chicken/Egypt/SCU9/2014 (SCU9) and A/chicken/Egypt/ 
SCU20/2014 (SCU20) were characterized to understand the origin, molecular epidemiology and 
distribution of the viruses in respective countries. 
 
6.2.1 H9N2 in chicken in Bangladesh 
In Bangladesh AIV H9N2 infections in domestic poultry, especially in commercial and backyard 
chickens became geographically widespread across the country causing serious economic losses. Besides 
LPAIV H9N2, HPAIV H5N1 is co circulating in domestic poultry raised the possibility of reassortments 
between the gene segments of LPAIV and HPAIV or the occurrence of mixed infections.  
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6.2.1.1 Bangladeshi H9N2 as a donor for other HPAI 
The phylogenetic analysis of the surface glycoprotein (HA and NA) suggested that the Bangladeshi H9N2 
closely related to other South Asian and the Middle Eastern isolates, forming a distinct cluster. This 
defined cluster maintained a direct out-group relation with the prototype HK-G1which confirmed that the 
BD-VP01 belonged to the G1 lineage (Publication 2). The internal genes of the Bangladeshi isolate 
showed more genotypic differentiation such as the M and NP gene maintained a direct out-group relation 
with G1 like the HA and NA whereas, the NS, PA, PB1 and PB2 genes grouped under Kr-p96323 
prototypes. Moreover, the all six internal genes have 96 to 98% nucleotide homology with the HPAIV of 
subtype H7N3 from Pakistan (NARC-100/H7N3). In internal gene phylogeny, the NARC-100/H7N3 
always maintained a direct group relationship with BD-VP01 along with other South Asian and Middle 
Eastern H9N2 isolates. Furthermore, The PB1 gene of BD-VP01 showed maximum identity (98%) with a 
HPAIV H5N1 isolate from Bangladesh (Ck-BD/H5N1) and clustered together in a same branch of the 
phylogenetic tree. Briefly, the results suggested that HPAIV subtype H7N3 had all six internal genes like 
H9N2 (like BD-VP01, other South-Asian and Middle-Eastern H9N2) and at the same time HPAIV 
subtype H5N1 (CK-BD/H5N1) had also BD-VP01-like PB1gene. That means H9N2 act as a donor for 
those internal genes to the respective HPAI virus subtypes (Fig. 6). Previously the H9N2 has been 
described as a donor for internal genes of subtype H5N1 (GUAN et al. 1999).  
 
A very recent human infection with AIV H7N9 in China was recorded. This H7N9 virus contained all 6 
internal genes from AIV H9N2 (GAO et al. 2013; KAGEYAMA et al. 2013) which supported the current 
study. On the other hand, a reassortant genotype of AIV H9N2 containing the NS and NP genes similar to 
AIV of subtype H7N3, H5N1, H7N1, H6N1 was also described (KWON  et al. 2006; ZHANG  et al. 
2009; MUNIR et al. 2009) where H9N2 received genes from HPAIV. Thus, AIV H9N2 contributed in 
several cases to the genetic reassortment either by receiving genes from or donating genes to other 
subtype of AIV. In the current study, reassortment events occurred by indirect donation of six internal 
genes to the HPAIV subtype H7N3 and by the direct donation of the PB1 gene to the subtype HPAIV 
H5N1. BD-VP01 was isolated in 2006 while NARC-100/H7N3 was isolated in 2004. As this H7N3 virus 
showed homology of all internal genes with BD-VP01 along with other H9N2 viruses of south-east Asia 
from 2000-2006, the current study suggested that HPAIV H7N3 received those internal genes from 
previously mentioned circulating AIV H9N2. Therefore, the H9N2 strains isolated from Middle East and 
south-east Asia (2000-2004) might have served as a direct donor for those internal genes to HPAIV 
H7N3. It remains open in which direction the gene donation occurred. But the current study 
recommended that, the AIV H9N2 has to be the donor of those genes as all mentioned internal genes of 
HPAIV H7N3 always came into the brunch of H9N2 strains during NCBI blast search – never the other 
way around. For a better understanding we illustrated the possible reassortment events as shown in figure 
6. In case of the secondly described reassortment of the PB1 gene, it was surely a direct donation as Ck-
BD/H5N1 has a BD-VP01/H9N2 like PB1 gene. The isolation period and the country of origin of BD-
VP01 and Ck-BD/H5N1 also supported this notion. 
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Figure 6: Avian influenza reassortment events between AI BD-VP01/H9N2, HPAI NARC-100/H7N3 and 
HPAI Ck-BD/H5N1. 
 
6.2.1.2 Amino acid sequence analyses of AIV H9N2 from Bangladesh 
HA is the critical determinant of the pathogenicity with a clear structure of the cleavage site 
(HORIMOTO and KAWAOKA 2001; HORIMOTO and KAWAOKA 1994; KNIPE and HOWLEY 
2007). The analyzed BD-VP01 contains a di-basic KSSR whereas previous Bangladeshi AIV H9N2 
contain RSSR motifs at the HA cleavage site. Both have characteristics of low pathogenic viruses. The 
receptor binding specificity of HA is responsible for the host range restriction and changes in the aa can 
cause alteration of the binding specificity. The BD-VP01 contained substitutions like HK-G1, typical for 
human influenza virus association with preferential binding to α 2,6 linkage (KAWAOKA et al. 1994; 
HAGHIGHAT-JAHROMI et al. 2008) and also found to be important for transmission in ferrets (WAN 
et al. 2008). The HA1 protein of the Bangladeshi isolates contain five potential glycosylation site motifs 
which lack one site compared to HK-G1. It has been described that the alteration in the glycosylation 
pattern influences the adaptation of viruses to poultry (MATSUOKA et al. 2009; JI et al. 2010). 
The NA stalk length correlates with the efficiency of viral replication. The BD-VP01 did not show any 
stalk deletion compared to the reference group G1, Y280 and recently isolated other Bangladeshi HPAIV 
H5N1 isolates. It is known that longer stalk structures result in better viral replication (BAIGENT et al. 
2003) and deletion in the stalk region may be required during adaptation processes (MUNIER et al. 
2010). Analysis of the neuraminidase active or hemadsorbing site (HB) of NA revealed the acquisition of 
mutations in three loops associated with resistance to neuraminidase drug inhibitors. Almost all analyzed 
isolates in this study had the same features indicating that H9N2 viruses are commonly resistance to 
neuraminidase inhibitors. 
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The influenza virus polymerase is responsible for pathogenicity and host adaptation (GABRIEL et al. 
2005; GAO et al. 2009). At position 627 of the PB2 protein, BD-VP01 displayed glutamic acid (E), 
which is common in AIV while human influenza possesses lysine (K). A single aa substitution (E627K) 
can significantly increase pathogenicity and enhance replication in mammalian hosts (HATTA et al. 
2001; WU et al. 2009). Proline (P) at position 13 of the PB1 protein can increase the polymerase activity 
in new hosts which was also observed in BD-VP01. The PB1-F2 protein is important for promoting viral 
pathogenicity and the existence of the full-length protein contributes to an increase in virulence 
(ZAMARIN et al. 2006). Genetic analysis of BD-VP01 determined a full length PB1-F2 protein. 
However, the virus did not show the N66S mutation which confers increased disease severity and 
cytokine production in mice (CONENELLO et al. 2007). Based on the PA protein analysis, BD-VP01 
contains unique mutations at position 305, 337 and 365 which were not found in other representative AIV 
H9N2 isolates. Their specific function(s) and relation with molecular determinants of pathogenicity are 
currently unknown. The Bangladeshi H9N2 virus also exhibited the recently identified PA-X protein 
(JAGGER et al. 2012) with a length of 252 aa. The main function of the NP protein is encapsulation of 
the viral genome to form the RNP complex associated with major determinants of host genetic signatures 
(SHAW et al. 2002). BD-VP01 had aa substitutions at position 136 and 372 which differ from AIV H9N2 
prototypes but are similar with some Pakistani AIV H9N2 and with the NARC-100/H7N3 virus.  
Molecular analysis of the NS1 protein displayed 230 aa in length, which is typical for H9N2 viruses. It 
has been previously described that the NS1 protein possesses strain specific aa length in birds and 
mammalian hosts (HALE et al. 2008) and deletion of five aa (80-84) along with the D29E mutation have 
caused increase virulence in chickens and mice (LONG et al. 2008). BD-VP01 exhibited a KSEV C-
terminal motif which is also found in some Indian and Pakistani isolates and NARC-100. However, the 
role of the NS1 C-terminal aa with regard to the pathogenesis of H9N2 viruses in poultry remains 
unknown. Bangladeshi AIV H9N2 contained NEP of 121 aa length but did not revealed such important 
mutations. The conserved aa residues in M is associated with host range, increase virulence or replication 
in mammalian hosts (SHAW et al. 2002). BD-VP01/H9N2 showed isoleucine (I) at position 15 of M1 
which is conserved within H9N2 viruses. Thus, the Bangladeshi AIV H9N2 exhibited particular genetic 
features and most importantly took part on the genetic reassortment of internal genes with two distinct 
HPAI viruses of subtypes H7N3 and H5N1.  
 
6.2.2 H9N2 in chickens in Egypt 
H9N2 influenza virus was identified and described in Egyptian commercial broiler breeder farms for the 
first time in 2010 (MONNE et al. 2013). The present study described H9N2 outbreaks in commercial 
broiler breeder farms suffered from respiratory manifestations during the period January to May 2014 and 
the molecular characterization of the isolated viruses. The general health signs started with mild 
respiratory manifestation and low mortality rates. The high mortality could be attributed to opportunistic 
pathogens or immune-suppression (BANO et al. 2003; KISHIDA et al. 2004). Three avian influenza 
viruses of subtype H9N2 (SCU8, SCU9, SCU20) were isolated in SPF embryonated chicken eggs. It was 
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very useful to understand the evolutionary status of the recurrent viruses, hence the three recurrent viruses 
were isolated during a short period, the interval between the first (SCU8) and the last isolate (SCU20) 
was less than five months. In addition, due to circulation of HPAIV H5N1 simultaneously with AIV 
H9N2 can elucidate potential reassortments.  
Phylogenetic analyses revealed that the three isolated viruses were closely related to the other 
contemporary Egyptian strains as well as to the isolates from Israel. The virus shared the common 
ancestor with the HK-G1 prototype which has contributed the internal genes to the HPAIV H5N1 virus 
circulating in Asia (GUAN et al. 1999). The currently circulating Egyptian isolates from 2011-2014 
exhibited similar genetic relation with 98-99% nucleotide homology. The other important surface 
glycoprotein NA gene - along with six internal genes of SCU8, SCU9 and SCU20 viruses - is also closely 
related to the recent Egyptian AIV H9N2 isolated from chickens and quails. In the separate eight gene 
phylogenetic trees, all contemporary Egyptian isolates created a large cluster suggesting that the same 
genotype of AIV H9N2 are circulation throughout the country. 
The aa sequence analyses of three Egyptian AIV H9N2 revealed regular point mutations. The cleavage 
site motif of the studied viruses was PARSSR/GLF indicative of low pathogenic features. However, the 
sequence is similar to the RX-RYK-R (KAOWAOKA and WEBESTER 1988) genetic constitution which 
suggests that these viruses may have the potential to acquire additional basic amino acids needed to 
become HPAIV (ABDEL-MONEIM et al. 2012). The RBS motif of the HA protein of the SCU8 and 
SCU20 AIV H9N2 revealed an important Q234L mutation like other G1 strains, however; the SCU9 
virus contains Q at 234 positions (H3 numbering: 226). The presence of Q226 is a typical avian virus 
signature. It has been reported that the presence of this aa results in a preference for binding to α 2,3-
linked SA (avian receptors) whereas viruses having L234 showed a preference for binding to 2,6-linked 
SA (human receptors) and a potential cause of reported human infections (WAN and PEREZ 2007). The 
three recurrent isolates have five potential glycosylation sites at positions 29, 105, 141, 298 and 305 
within the HA1 molecule indicating that these viruses lack one site compared with HK-G1. The alteration 
in the glycosylation pattern influences the adaptation of viruses to poultry (WAN et al. 2008). The loss of 
an N-linked glycosylation site located near the RBS enhanced virus binding to α 2,6-linked SA (WANG 
et al. 2010). The balance between HA and NA is crucial for virus replication and transmission. HA binds 
to SA and NA cleaves it from the host cell surface (WAGNER et al. 2002). The studied Egyptian viruses 
contained aa mutations on the HB sites. This site interacts directly with sialic acid and is associated with 
NA inhibitor drug resistance, compared to other recent Egyptian isolates and HK-G1 (Publication 3). The 
neuraminidase stalk deletion was absent while, it was present in HK-G1.  
Four critical sites were reported to be associated with amantadine resistance. Single amino acid 
substitutions L26F, V27T, A30T/V and S31N/R in the transmembrane region of the M2 protein may 
confer drug resistance as well as aa substitutions at position 34 or 38 (SCHNELL and CHAU 2008; 
SUZUKI et al. 2014). Analysis of the M2 protein showed that the SCU8, SCU9 and SCU20 viruses are 
sensitive to M2-blockers in which none of such amino acid substitutions were found. They have aa 
substitution I15 V in M1 which is quite common in AIV H9N2 isolates but differ from AIV signatures 
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(PARVIN et al. 2014a). The currently isolated Egyptian isolates exhibited three human specific residues; 
E14, G16, and R18 (DE FILETTE et al. 2006). In recent years, the influenza virus polymerase complex 
has emerged as a major determinant of interspecies transmission and pathogenicity (GABRIEL and 
FODOR 2014). Molecular analysis of Egyptian viruses revealed that these viruses had E627, N701, and 
R714 in the PB2. The E627K substitution is the best characterized mammalian adaptation and can 
dramatically increase the pathogenicity (HATTA et al. 2001). The Egyptian viruses had the V14A 
substitution in PB1 protein which reduced polymerase activity, viral shedding and transmissibility but did 
not affect pathogenicity in chickens (SUZUKI et al. 2014). Also the currently isolated viruses had Y at 
position 38. The C38Y substitution in PB1 of LPAIV isolated from wild birds demonstrated that this 
substitution increased both polymerase activity in DF-1 cells in vitro and the pathogenicity of the 
recombinant viruses in chickens (SUZUKI et al. 2014). PB1-F2 is a 90 amino acid protein that is 
expressed from the +1open reading frame in the PB1 gene of some influenza A viruses and has been 
shown to contribute to viral pathogenicity (VARGA et al. 2011). The currently isolated Egyptian AIV 
H9N2 had a N66S mutation in the PB1-F2 protein. Also the currently isolated Egyptian isolates had T68, 
Q69 and V70 in the PB1-F2 protein. Recently, the cytotoxic sequence I68, L69, and V70 of A/Puerto 
Rico/8/34 PB1-F2 was shown to contribute to the pathogenesis of both primary viral and secondary 
bacterial infections (ALYMOVA et al. 2014). The NS1 protein was 230 aa long and contained the 
‘KSEV’ PDZ ligand (PL) motif at the C-terminal end. Most AIVs possess ESEV PL motifs at the end of 
NS1 protein.  
 
6.3 Biological Characterization of Eurasian-H9N2 
Considering the above mentioned mutations, genotypic variation and gene segment reassortments further 
studies were designed to check growth kinetic, the molecular basis of cell tropism and host response. As 
the AI outbreaks are still ongoing events in many countries of Asia, the Middle East and Europe. 
Therefore continued monitoring, surveillance and molecular genetic analysis of circulating viruses are 
highly recommended. In this context efficient isolation and detection of AIVs from surveillance samples 
continue to be of high priority. 
The replication of influenza virus in a host cell is a polygenic process depending on the host cell 
endocytic pathways for entry and transfer of viral genome as well as activation of host cell signaling 
(LAKADAMYALI et al. 2004; ZHANG 2009). Preferentially, AIV bind to terminal α-2,3 SA linkage, 
whereas human influenza bind to α-2,6 SA (KNIPE and HOWLEY 2007). The binding property of the 
virus to the host cell is determined by two factors, the receptor binding site (RBS) affinity of the virus and 
receptor density on the host cell surface (ASAOKA et al. 2006). In this study, we selected four Eurasian 
lineage H9N2 viruses: A/chicken/Bangladesh/VP01/2006 (BVP01), A/turkey/Germany/R869/2012 
(GR869), A/chicken/Saudi Arabia/R61/2002 (SAR61) and A/chicken/Dubai/ F5/2013 (DF5) for 
successful propagation in embryonated chicken eggs (ECE) and in cell culture (Publication 4). Following 
isolation, virus replication kinetics were compared based on three viral quantification methods; tissue 
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culture infectious dose (TCID50) titer, hemagglutination (HA) titer and quantitative real time PCR (qRT-
PCR) based on Matrix (M) genome copies.  
 
6.3.1 Replication properties of AIV H9N2 viruses in ECE 
AIV isolation is traditionally carried out in ECE since many years. Cultivation of influenza virus in ECE 
is the system of choice for generating large quantities of virus used in the laboratory studies (KNIPE and 
HOWLEY 2007) as well as for vaccine production (ROBERTSON et al. 1995). The four selected H9N2 
viruses were cultivated successfully and we were able to measure the amount of virus production at 
various time points. The BVP01 and DF5 replicated to the highest titer followed by SAR61 and the 
lowest titer was calculated for GR869 measured from all the quantification methods. On TCID50 count, 
the BVP01 and DF5 viruses reached maximum yields (~8 log10 TCID50/ml) followed by SAR61 (~7 log10 
TCID50/ml) and GR869 (~5 log10 TCID50/ml). The highest HA titers reached by BVP01, DF5, SAR61 and 
GR869 were 9log2 (512), 9log2 (512), 8 log2 (256) and 5 log2 (32), respectively. Furthermore, the 
maximum genome copy number (about 7 log10 genome copies/reaction) was obtained for BVP01 and 
DF5 followed by about 5.5 log10 genome copies/reaction for SAR61 and about 5 log10 genome 
copies/reaction for GR869. Apart from the measurement of the titer at respective time points, the time 
when all the viruses started to grow well with a detectable titer were also measured. Following an 
infection in the ECE system, the virus initially appears on the surface of the allantoic membrane 
epithelium, then in the vascular endothelial cells of chorioallantoic membrane and the visceral organs of 
the embryo (PARK et al. 2001). In contrast to the HPAI strains, the LPAI viruses are mostly confined in 
the allantoic membrane and may not kill the embryo. Our four studied H9N2 viruses did not kill the 
embryos which allowed better replication until the last time point set for this experiment. Additionally, 
the allantoic cells of the chicken embryo contain the Neu5Acα-2, 3Gal which allowed the AIV to bind to 
the specific receptor as well as support better replication (ITO et al. 1997).  
 
6.3.2 Replication properties of AIV H9N2 viruses in MDCK cell culture 
The Madin-Darby canine kidney (MDCK) is the cell line of choice using for a wide variety of Influenza 
A virus propagation including human, equine, porcine and avian origins (TOBITA et al. 1975) and is also 
recommended by the World Health Organization (WHO 2007). Additionally, the MDCK cells contain 
both avian and human origin receptor linkages (ITO et al. 1997). The availability of the cells from the cell 
bank and the freedom of other microbial contaminations is the advantage of the cell line (OXFORD et al. 
2003). Although, the four selected H9N2 viruses were successfully cultivated, the overall achievement of 
the virus yields was 2-3 folds lower than the ECE-grown viruses. The replication patterns produced the 
four H9N2 viruses, however, was similar to the ECE-grown viruses. Thus, the cell culture-grown BVP01 
and DF5 also exhibited higher titers when compared with SAR61 and GR869. On TCID50 count, the 
BVP01 and DF5 viruses reached maximum yields (~5 log10 TCID50/ml) followed by SAR61 (~4 log10 
TCID50/ml) and GR869 (2.8 log10 TCID50/ml). The HA titers observed by BVP01, DF5, SAR61 and 
GR869 were 7log2 (128), 7log2 (128), 5log2 (32) and 3log2 (8), respectively. However, the cell culture-
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grown viruses exhibited maximum copy number of >6 log10 genome copies/reaction for the BVP01 and 
DF5, about 5 log10 genome copies/reaction for the SAR61 and ~4.3 log10 genome copies/reaction for the 
GR869 which is 1-1.5 fold lower than the ECE grown viruses. Although the qRT-PCR method does not 
take into account the infectious properties of the virus rather can also detect defective virus particles. 
 
On morphology, the viruses caused CPE inverted microscopy earliest at 16 hpi, although the viral 
replication was detected at 8hpi when tested against nucleoprotein (NP) of AIV in IF stain. Additionally it 
was found that on TCID50 count the presence of the virus by producing CPE was confirmed at the 2nd 
dilution while the virus was actually present until the 5th dilution as confirmed by IF stain. Thus, the 
TCID50 titers were considered not only based on CPE but also considering the highest dilution where NP 
protein was recognized by IF stain. At the early time points of infection the viral NP protein was mainly 
detected in the nucleus and later disseminated to the cytoplasm which has also been described by others 
(KNIPE and HOWLEY 2007). Significant damage and loss of nuclear structure of the cells at later time 
points was clearly observed by DAPI stain alone (Fig. 7). Thus, one can also observed the morphological 
changes of the infected cell’s nucleus by comparing with the control DAPI stain without the use of 
specific antibody stain in IF assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Morphological changes of the cell’s nucleus at different time points produced by DF5/H9N2 in 
MDCK-II cell observed by immunofluorescence assay (magnification 20x). I: infected cells positive for 
DAPI stain and C: mock control positive for DAPI stain. 
 
In summary, the replication properties of H9N2 virus on ECE and cell culture system depends on several 
factors such as the viral dose or multiplicity of infection, molecular genetic properties of the virus, 
receptor binding properties of the host cell and some other virus- or host-related factors (LEBAS et al. 
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2013; HUSSAIN et al 2010; YOUIL et al. 2004). The genetic variations among the four studied viruses 
and the two different biological cultivation systems triggered the variations in replication kinetics. The 
three different quantification methods might have some effect on different replication kinetics but are 
insignificant.  
 
6.3.3 Amantadine sensitivity of the viruses 
Amantadine blocks the ion channel formed by M2 protein and inhibits the early step of replication. 
Substitutions of aa residue such as L26F, V27A, A30T, S31N and G34E of the M2 protein are already 
known to confer resistance to amantadine (BELSCHE et al. 1988; HAY et al.1986). The aa residue 
analysis of the M2 protein of all studied H9N2 viruses did not showed any substitutions on those 
conserved residues (Publication 4). Furthermore, the amantadine screening on cell culture (MDCK-II) at 
two different concentrations also confirmed their sensitivity to the amantadine M2 blocker drug. Thus, all 
studied H9N2 viruses are sensitive to amantadine.  
 
6.3.4 Adaptive mutation of the viruses in cell culture after single passage 
The HA, NA and NS genes plays an important role in host-virus interaction and virulence of influenza 
virus in target cells (KNIPE and HOWLEY 2007). Thus, the respective gene sequences of cell culture-
grown viruses were compared to the original sequences of the stock virus used as inoculum. The analysis 
of the three genes revealed several nucleotide changes resulting in 1 to 2 aa substitutions depending on 
the respective gene (Publication 4). However, none of these amino acid mutations was observed in the 
conserved regions, which have been described to alter influenza virus pathogenesis or virulence (KNIPE 
and HOWLEY 2007; HORIMOTO and KAWAOKA 1994; BAIGENT and MCCAULEY 2003). 
 
6.4 Conclusion 
Migratory birds have played an important role in new clade introductions of HPAIV H5N1 in domestic 
avian species in Bangladesh. The characterized two new H5N1 strains have been described genetically 
similar with the contemporary isolates from other avian species in Bangladesh. The Bangladeshi and 
Egyptian AIV H9N2 isolates belonged to the H9N2 G1-lineage. The Bangladeshi AIV H9N2 strain 
exhibited two independent reassortment with HPAI subtype H7N3 and H5N1 viruses whereas the 
Egyptian AIV H9N2 strains were limited to regular point mutations. The newly characterized AIV H9N2 
strains were found to have acquired mutations like HK-G. No further genomic changes were determined 
in specific conserved regions that can alter pathogenesis and host range. Among four biologically 
characterized viruses, the three G1-H9N2 viruses supported the high replication profile when compared to 
European wild bird-H9N2 virus. The ECE-grown viruses derived growth kinetics was relatively high in 
contrast to the cell culture-grown viruses derived growth kinetics. There was a phenomenal correlation 
between the three different virus quantification methods. Nevertheless, all four biologically characterized 
H9N2 viruses were sensitive to amantadine. Thus the antiviral drug is able to inhibit viral replication. 
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Introduction 
Avian influenza viruses (AIVs) are the major cause of significant disease outbreaks with high morbidity 
and mortality worldwide in domestic birds resulting in great economic losses. Especially the subtypes of 
highly pathogenic avian influenza viruses (HPAIV) H5N1 and low pathogenic avian influenza viruses 
(LPAIV) H9N2 became the most prevalent AIVs in poultry causing regular disease outbreaks in many 
countries of Asia, the Middle East and Europe and are still ongoing events. Therefore, continues 
monitoring, surveillance and characterization of the circulating viruses are of high priority.  
Objectives 
The current study was designed for three main objectives; i) Molecular epidemiology of the HPAIV 
H5N1 in migratory birds in Bangladesh, ii) Molecular characterization of the AIV subtype H9N2 and iii) 
Biological properties of the AIV subtype H9N2.   
Materials and methods 
In first the part of the investigations, two HPAIV H5N1 strains were confirmed from 205 pools of fecal 
surveillance samples in Bangladesh. The two isolated H5N1 viruses were characterized by genome 
amplification and sequence analysis of the all eight genome segments. In the second part of the 
investigations, a confirmed AIV H9N2 from a retrospective analysis derived from a poultry farm in 
Bangladesh was characterized. Furthermore, three AI-H9N2 viruses were isolated and characterized from 
a commercial broiler and broiler breeder flock with clinical respiratory manifestations in Egypt. Full 
length genome amplification, cloning, sequencing and comprehensive phylogenetic analyses were 
performed for all eight genome segments. In the final part of the study, four selected Eurasian lineage 
H9N2 viruses - three G1 sub-lineages H9N2 and one European wild bird H9N2 virus - were propagated 
in embryonated chicken eggs (ECE) and Madin-Darby canine kidney epithelial cell culture systems. The 
ECE-grown and cell culture-grown viruses were monitored for replication kinetics based on tissue culture 
infectious dose (TCID50), hemagglutination assay (HA) and quantitative real time RT-PCR (qRT-PCR). 
The cellular morphology after infections was analyzed by immunofluorescence assay and cellular ELISA 
was performed to screen the sensitivity of the viruses to amantadine. 
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Results 
The two newly isolated HPAIV H5N1 strains from migratory birds belonged to clade 2.3.2.1 and 
clustered together with other recently isolated viruses in Bangladesh derived from ducks, chickens, quails 
and crow. The amino acid sequences were also genetically similar although, some unique amino acid 
substitutions were observed. These substitutions were not related to the known conserved region of the 
molecular determinants of the virus.  
The phylogenetic analyses of the isolated AIV H9N2 from Bangladesh and Egypt revealed their close 
relationship with their respective contemporary isolates and maintained ancestor relation with 
A/Quail/HK/G1/1997 confirming that all studied H9N2 belonged to G1 sub-lineage. All six internal gene 
segments of the Bangladeshi AIV H9N2 showed high sequence homology with the HPAIV subtype 
H7N3 from Pakistan. In addition, also the PB1 internal gene showed high nucleotide homologies with a 
recently circulating HPAI-H5N1 virus from Bangladesh. Thus, the Bangladeshi AIV H9N2 is genetically 
a unique strain which shares internal gene segments with different HPAI viruses and takes part in 
reassortment events. On the other hand, the internal gene segments of the Egyptian H9N2 viruses were 
similar to the other members of the G1 sub-lineage with no evidence of reassortment events. In this virus 
rather point mutations within their respective gene segments are observed.  
With regard to the biological characterization, the three G1-H9N2 viruses produced comparatively higher 
titer than the Eurasian wild type-AIV H9N2. Overall, the ECE-grown viruses yielded higher titers than 
cell culture-grown viruses. Following a single passage in cell culture, individual nucleotide substitutions 
were noticed in HA, NA and NS gene sequences but none of them are related to the conserved region that 
can alter virus pathogenesis or virulence. All of the studied H9N2 viruses were sensitive to amantadine.  
 
Conclusion 
The present study demonstrated for the first time the presence of HPAI H5N1 in the wild migratory bird 
population in Bangladesh and determine as one of the major cause to introduce the new clade of HPAIV 
H5N1 into the Bangladeshi poultry flocks. The Bangladeshi AIV H9N2 strain has exhibited two 
independent reassortment events with HPAIV of subtype H7N3 and H5N1.The Egyptian AIV H9N2 
strains were limited to regular point mutations which is very common for AIVs. The G1-H9N2 viruses 
showed a higher replication profile when compared to European wild bird-AIV H9N2. Both the ECE and 
MDCK cell system allowed efficient replication but the ECE system is considered as the better cultivation 
system for H9N2 viruses in order to get maximum amounts of virus within a short time period. In this 
study new strains of AIV H9N2 and H5N1 with significant genetic constitutions were described. Thus, 
continuous monitoring of the field samples, rapid reporting soon after outbreaks, molecular 
characterization to confirm the emergence of new reassortant strains and the biological properties to know 
its impact on the virulence are recommended. 
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Einleitung 
Weltweit kommt es in der Geflügelproduktion durch Infektionen mit aviären Influenzaviren (AIV) zu 
hohen Morbiditäts- und Mortalitätsraten und damit verbunden zu hohen wirtschaftlichen Verlusten. Zu 
den bedeutenden AIV in der Geflügelwirtschaft werden die hoch pathogenen aviären Influenzaviren 
(HPAIV) des Subtyps H5N1 sowie AIV des Subtyps H9N2 gezählt. Letztere besitzen die Charakteristika 
von niedrigpathogenen aviären Influenzaviren. Durch diese Subtypen kommt es regelmäßig in vielen 
Ländern in Asien, im Nahen Osten und Europa zu wiederholten Krankheitsgeschehen. Dies bedingt die 
dringende Notwendigkeit von andauerndem Monitoring, Überwachung und Charakterisierung der 
zirkulierenden Viren. 
Ziele der Untersuchungen 
Die vorliegende Studie soll folgende drei Hauptfragestellungen beantworten: i) Molekulare 
Epidemiologie des HPAIV H5N1 bei Zugvögeln in Bangladesch, ii) Molekulare Charakterisierung von 
AIV des Subtyps H9N2 und iii) Biologische Eigenschaften von AIV des Subtyps H9N2. 
Materialien und Methoden 
Der erste Teil der Arbeit befasst sich mit zwei HPAIV Stämmen des Subtyps H5N1, welche im 
Monitoring Programm in Bangladesch von insgesamt 205 gepolten Kotproben, isoliert wurden. Die 
Charakterisierung der beiden Isolate erfolgte durch Vervielfältigung der acht Genomsegmente und 
nachfolgende phylogenetische Analysen. Der zweite Teil der Arbeit beschreibt die retrospektive Analyse 
eines AIV des Subtyps H9N2, welches von einer Geflügelproduktionsanlage in Bangladesch eingesandt 
wurde. Weiterhin wurden aus einer Geflügelmast- und Legehennenhaltung mit respiratorischer 
Symptomatik drei AIV des Subtyps H9N2 isoliert und charakterisiert. Auch hier wurde das gesamte 
Genom amplifiziert, kloniert und nachfolgend phylogenetisch analysiert. Im letzten Teil der Studie 
wurden vier europäische AIV H9N2 Isolate, von welchen 3 Isolate zur H9N2 Sublinie G1 gehören und 
ein Isolat von einem Wildvogel selektiert und in embryonierten Hühnereiern (EHE) und auf Madin-Darby 
canine kidney (MDCK) Zellen passagiert. Mittels 50% tissue culture infectious dose (TCID50), 
Hämagglutinationstest (HA) und RT-real-time-PCR (qRT-PCR) wurden von diesen so passagierten Viren 
die Vermehrungskinetik bestimmt. Die Morphologie der infizierten Zellen nach Infektion wurde mittels 
Immunfluoreszenztest analysiert. Eine Bestimmung der Amantadin Empfindlichkeit dieser Viren erfolgte 
mit einem ELISA. 
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Ergebnisse 
Die beiden neuen HPAIV des Subtyps H5N1 von Zugvögeln können in die Clade 2.3.2.1 eingeordnet 
werden und clustern mit kürzlich aus Enten, Hühnern, Wachteln und Krähen isolierten AIV aus 
Bangladesch. Eine Verwandtschaft der Viren konnte auch auf Ebene der Aminosäure Sequenz gezeigt 
werden, obwohl einige einzigartige Aminosäure Austausche nachgewiesen wurden. Diese Austausche 
zeigen keine Verbindung mit bekannten konservierten Regionen der molekularen Determinanten der 
Viren. Die phylogenetische Analyse der AIV aus Bangladesch und Ägypten zeigt eine deutliche 
Verbindung mit den derzeit zirkulierenden AIV auf diesem geographischen Gebiet sowie die 
Verwandtschaft zu dem Isolat A/Quail/HK/G1/1997. Dies bestätigt, dass die in dieser Studie analysierten 
AIV zu der Subline G1 gehören. Alle sechs internen Gensegmente des AIV H9N2 aus Bangladesch 
zeigen eine hohe Sequenz Homologie mit einem HPAIV des Subtyps H7N3 aus Pakistan. Zusätzlich 
zeigt das interne Gene PB1 eine hohe Homologie auf Nukleinsäureebene zu einem derzeit in Bangladesch 
zirkulierenden HPAIV des Subtyps H5N1. Somit ist das AIV H9N2 aus Bangladesch als ein einzigartiges 
Isolat anzusehen, welches durch Reassortierung interne Gensegmente mit hochpathogenen AIV teilt. Im 
Gegensatz dazu, sind die internen Gene des AIV H9N2 aus Ägypten sehr ähnlich zu anderen Mitgliedern 
der Sublinie G1, welche keine Hinweise auf Reassorierung zeigen. Nur einzelne Punktmutationen 
konnten in den entsprechenden Gensegmenten nachgewiesen werden. 
In Hinblick auf die biologische Charakterisierung, konnte in den drei AIV H9N2 der Sublinie G1 
vergleichsweise höhere Titer nachgewiesen werden als in einem europäischen AIV H9N2 Wildtypisolat. 
Insgesamt zeigten die in EHE passagierten Viren höhere Titer als die MDCK-Zell passagierten Viren. 
Schon nach einer Passage auf Zellkultur konnten einzelne Nukleotidaustausche in den HA, NA und NS 
kodierenden Gensegmenten nachgewiesen werden, wobei keine dieser Veränderungen einen Einfluss auf 
konservierte Regionen haben, die die Pathogenese oder Virulenz der Viren beeinflussen. Alle 
untersuchten H9N2 Viren sind sensitiv gegenüber Amantadin. 
Schlussfolgerungen 
Die vorliegende Studie zeigt erstmalig das Vorkommen von HPAIV H5N1 bei Zugvögeln in 
Bangladesch, welches als Haupteintragsquelle der neuen HPAIV H5N1 in der dortigen Geflügelhaltung 
angesehen wird. Das AIV H9N2 aus Bangladesch zeigt zwei unabhängige Reassortierungen mit HPAIV 
des Subtyps H7N3 und H5N1. Hingegen zeigt das ägyptische AIV H9N2 Punktmutationen, welche sehr 
typisch für diese Viren sind. Die hier untersuchten AIV H9N2 der Sublinie G1 zeigen im Vergleich zu 
einem europäischen AIV H9N2 eine höhere Replikationsrate. Eine Replikation der Viren konnte in EHE 
und MDCK-Zellen gezeigt werden, jedoch wird das EHE als das geeignetere System für die Kultivierung 
von H9N2 Viren betrachtet, da hier in einer kürzeren Zeitspanne mehr Virus produziert werden kann. Des 
Weiteren konnten in dieser Studie neue Isolate von AIV des Subtyps H9N2 und H5N1mit einem 
bedeutenden genetischen Aufbau beschrieben werden. Daher wird ein kontinuierliches Monitoring von 
Feldproben, unverzügliche Meldung von Ausbruchsgeschehen, die molekulare Charakterisierung zur 
Dokumentation eventuell auftretender neuer Reassortanten sowie Untersuchungen der biologischer 
Eigenschaften zur Virulenzbestimmung empfohlen. 
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